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SCREENINGS IN FINLAND 2014
The present state of health care screenings and future prospects
  The screenings to promote health have long traditions in Finland. Since 
2003 the working group on screenings set up by the Ministry of Social Affairs 
and Health has evaluated the health care screening programmes being carried 
out, those proposed to be carried out and their methods.
According to the Health Care Act, local authorities must organise 
screenings in accordance with the national screening programme for the 
municipal residents. Those are listed in the Screenings Decree: screening for 
breast cancer for women aged 50 to 69 years at about two years’ intervals, 
screening for cervical cancer for women aged 30 to 60 years at five years’ 
intervals, and prenatal screenings for pregnant women. Prenatal screening 
comprises general ultrasound during early pregnancy, finding a risk of 
chromosomal abnormalities, and ultrasound for finding severe structural 
abnormalities. 
The screenings are steered nationally by both standards and in a less 
binding form by information. Apart from the screenings prescribed by the 
Decree, the organisers of screenings can choose fairly independently both the 
screenings offered and how they are implemented. National steering has been 
increased in several countries in regard to the screening of individual diseases 
so as to ensure equality. A wide discussion in society about the objectives and 
effects of screenings provides a good basis for the steering. 
Including a new screening test in the national screening programme 
demands a great deal of preparatory work. Public debate and an efficient 
support for the implementation further the acceptability of a screening 
and contribute to establishing uniform practices. Those also increase the 
participation activity of the target population. In the present report, the 
introduction of prenatal screenings is used as an example of preparing a new 
screening and embedding it in practice in Finland. 
A screening should produce enough health benefits to be justified from the 
perspective of public health. Therefore there must be a good understanding 
of the benefits, costs and societal impacts of a screening until a decision is 
made to start a new screening programme. Many screenings have been started 
on the initiative of health care professionals without particular steering. 
In Finland the effectiveness of statutory screenings has also been assessed 
afterwards. Sometimes the evaluation of a screening shows that it is not useful 
enough to be started. The present report deals with the following screenings 
4evaluated by the working group on screenings: infection screening in early 
pregnancy, streptococci screening during pregnancy, screening for metabolic 
disorders in newborn infants, screening for aorta-aneurysma, and newborn 
hearing screening
The effectiveness of certain cancer screenings has been proved, but 
all cancer screenings are not necessarily useful. There must be a balance 
between the advantages and disadvantages of a screening. The application of 
a screening test that has proved effective in a research design in a population 
screening programme may prove less effective than was expected. The 
screening registers are important in view of evaluating and monitoring the 
implementation of the screenings, participation in them and above all their 
effectiveness at the population level. 
Health examinations are included in the report since screenings and 
health examinations are not distinguished very clearly in public debate. 
Health examinations may include elements of screening but the aim of health 
examinations is not only to find diseases and precursors to them but also to 
support people’s health, wellbeing and work ability. In health examinations 
of children and adolescents the focus is on monitoring and supporting their 
health and development, and as regards adults on promoting their health, 
functional capacity and work ability. 
We hope that the information and experiences conveyed by the report will 
be of benefit when planning screenings, their steering and quality monitoring 
in the future.
Key words:
cancer, effectiveness, equality, implementation, screening, 
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SEULONNAT SUOMESSA 2014
Terveydenhuollon seulontojen nykytila ja tulevaisuuden näkymät
  Terveyden edistämiseksi tehtävillä seulonnoilla on Suomessa pitkät perin-
teet. Vuodesta 2003 lähtien Sosiaali- ja terveysministeriön asettama seulonta-
työryhmä on arvioinut käynnissä olevia terveydenhuollon seulontaohjelmia, 
sellaisiksi ehdolla olevia ja niiden menetelmiä.
Terveydenhuoltolain mukaan kunnan on järjestettävä asukkailleen valta-
kunnallisen seulontaohjelman mukaiset seulonnat. Nämä on koottu seulonta-
asetukseen: rintasyöpäseulonta 50–69 -vuotiaille naisille noin kahden vuoden 
välein, kohdun kaulaosan syövän seulonta 30–60 -vuotiaille naisille viiden 
vuoden välein sekä sikiöseulonnat raskaana oleville. Sikiöseulontaan kuulu-
vat varhaisraskauden yleinen ultraäänitutkimus, kromosomipoikkeavuuksien 
riskin selvittäminen ja ultraäänitutkimus vaikeiden rakennepoikkeavuuksien 
selvittämiseksi. 
Seulontoja ohjataan kansallisesti sekä normein että vähemmän sitovan 
tiedolla ohjauksen avulla. Asetuksella säädettyjen seulontojen ulkopuolella 
seulonnan järjestäjät voivat valita sekä tarjottavat seulonnat että niiden to-
teutuksen melko itsenäisesti. Useissa maissa valtakunnallista ohjausta on vä-
hitellen lisätty yksittäisiä tauteja koskevien seulontojen osalta, jotta tasa-arvo 
toteutuisi. Laaja yhteiskunnallinen keskustelu seulontojen tavoitteista ja vai-
kutuksista on hyvä perusta ohjaukselle. 
Uuden seulonnan ottaminen mukaan valtakunnalliseen seulontaohjelmaan 
vaatii paljon valmistelutyötä. Julkinen keskustelu ja tehokas toimeenpanon 
tuki edesauttavat seulonnan hyväksyttävyyttä ja luovat pohjaa yhtenäisille 
toimintakäytännöille. Ne myös lisäävät kohdeväestön osallistumisaktiivisuut-
ta. Esimerkkinä uuden seulonnan valmistelusta ja juurruttamisesta käytetään 
tässä raportissa sikiöseulontojen aloittamista Suomessa.
Seulonnan pitää tuottaa kylliksi terveyttä, jotta sen tarjoaminen on kan-
santerveyden kannalta perusteltua. Niinpä seulonnan hyödyistä, kustannuk-
sista ja yhteiskunnallisista vaikutuksista on oltava hyvä käsitys, ennen kuin 
uusi seulontaohjelma päätetään aloittaa. Monet seulonnat ovat käynnistyneet 
terveydenhuollon ammattilaisten aloitteesta ilman erityistä ohjausta. Laki-
sääteisten seulontojen vaikuttavuutta on arvioitu Suomessa myös jälkikäteen. 
Tässä raportissa käsitellään seuraavia seulontatyöryhmässä arvioituja seulon-
toja: alkuraskauden infektioseula, raskausajan streptokokkiseula, aineenvaih-
duntatautien seulonta vastasyntyneillä, aortta-aneurysman seulonta sekä kuu-
lon seulonta vastasyntyneillä.
6Toisinaan seulonnan arviointi osoittaa, ettei se ole kyllin hyödyllistä aloi-
tettavaksi. Tiettyjen syöpäseulontojen vaikuttavuus on voitu osoittaa, mutta 
kaikki syöpäseulonnat eivät välttämättä ole hyödyllisiä. Seulonnan hyötyjen ja 
haittojen tulee olla tasapainossa. Tutkimusasetelmassa vaikuttavaksi todetun 
seulonnan soveltaminen väestöseulonnaksi voi osoittautua vaikutuksiltaan 
odotuksia pienemmäksi. Seulontarekisterit ovat tärkeitä, jotta seulontojen to-
teutusta, niihin osallistumista ja ennen kaikkea vaikuttavuutta väestötasolla 
voidaan arvioida ja seurata.
Terveystarkastukset on otettu tähän raporttiin mukaan, koska seulontojen 
ja terveystarkastusten välinen raja on yleisessä keskustelussa häilyvä. Terveys-
tarkastukset voivat sisältää seulontaelementtejä, mutta terveystarkastusten 
tavoite ei ole pelkästään sairauksien tai niiden esiasteiden löytäminen, vaan 
terveyden, hyvinvoinnin ja työkyvyn tukeminen. Lasten ja nuorten terveys-
tarkastuksissa korostuu kasvun ja kehityksen seuranta ja tukeminen, aikuisilla 
terveyden ja toimintakyvyn edistäminen sekä työkyvyn tuki.
Seulonnat ovat arvokas osa väestön hyvinvoinnin ja terveyden edistämistä. 
Sosiaali- ja terveysministeriön seulontatyöryhmä toivoo, että nyt julkaistava 
katsaus seulontatoiminnan historiaan ja nykytilaan antaisi hyvän pohjan suo-
malaisen seulontaohjelman jatkuvalle arvioinnille ja uudistamiselle myös tu-
levaisuuden uudessa sosiaali- ja terveydenhuollossa.
asiasanat:
ohjaus, seulonta, syöpä, tasa-arvo, toimeenpano, vaikuttavuus
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SCREENING I FINLAND 2014
Nuläge för screening inom hälso- och sjukvården och framtidsutsikter
  Screening som genomförs för att främja hälsa har långa traditioner i Finland. 
Från och med år 2003 har en screeningarbetsgrupp, som tillsatts av social- och 
hälsovårdsministeriet, bedömt pågående och föreslagna screeningprogram 
inom hälso- och sjukvården och deras metoder. 
Enligt hälso- och sjukvårdslagen ska en kommun ordna screening för sina 
invånare i enlighet med det nationella screeningprogrammet. En förteck-
ning över dessa screeningundersökningar ingår i förordningen om screening: 
bröstcancerscreening för kvinnor i åldern 50–69 med cirka två års intervaller, 
screening i syfte att förebygga cancer i livmoderhalsen hos kvinnor i åldern 
30–60 med fem års intervaller samt fosterscreening under graviditetstiden. 
Fosterscreening omfattar allmän ultraljudsundersökning under tidig gravidi-
tet, utredning av risken för kromosomavvikelser och ultraljudsundersökning 
för att utreda grava anatomiska avvikelser. 
Screening styrs nationellt genom både normer och mindre bindande in-
formationsstyrning. Utanför den screening som bestäms genom förordning 
kan de som ordnar screening välja både den screening som ska erbjudas och 
hur denna genomförs förhållandevis självständigt. I flertalet länder har den 
riksomfattande styrningen av screening som gäller enskilda sjukdomar efter 
hand ökats för att likvärdigheten ska förverkligas. En omfattande samhällelig 
diskussion om screeningens mål och effekt är en bra grund för styrning. 
Att införa en ny typ av screening i det nationella screeningprogrammet 
kräver mycket beredningsarbete. En offentlig diskussion och effektivt stöd för 
genomförandet bidrar till att en screening accepteras, och de skapar en grund 
för enhetlig verksamhetspraxis. De ökar också målbefolkningens deltagarak-
tivitet. Som exempel på beredning och förankring av ny screening används i 
denna rapport inledandet av fosterscreening i Finland.
Screeningen måste skapa tillräckligt hälsa för att den ska vara motiverad 
med avseende på folkhälsa. Därmed ska det finnas en bra uppfattning om 
nyttan med, kostnaderna för och de samhälleliga konsekvenserna av screening 
innan man bestämmer sig för att inleda ett nytt screeningprogram. Flera fall av 
screening har inletts på initiativ av yrkesutbildade personer inom hälso- och 
sjukvården utan särskild styrning. Effekten av lagstadgad screening har även 
bedömts i efterhand i Finland. Ibland visar en bedömning av screening att den 
inte är tillräckligt lönsam för att inledas. Denna rapport behandlar följande 
typer av screening som bedömts i screeningarbetsgruppen: infektionsscreen-
8ing under tidig graviditet, streptokockscreening under graviditet, screening av 
ämnesomsättningssjukdomar hos nyfödda, screening av aortaaneurysm och 
hörselscreening på nyfödda.
Effekten av en viss cancerscreening har kunnat bevisas, men all cancers-
creening är inte nödvändigtvis nyttig. För- och nackdelarna med screening ska 
vara i balans. Tillämpning av screening, som i undersökningskonstellationen 
konstaterats vara effektiv, som screening av befolkningen kan i fråga om ef-
fekten visa sig vara mindre än förväntat. Screeningregistren är viktiga för att 
genomförandet av screening, deltagandet i screening och framför allt effekten 
på befolkningsnivå kan bedömas och följas upp.
Hälsoundersökningarna har inkluderats i denna rapport eftersom gränsen 
mellan screening och hälsoundersökningar är svävande i den allmänna diskus-
sionen. Hälsoundersökningar kan innehålla element av screening, men målet 
med hälsoundersökningarna är inte enbart att hitta sjukdomar eller deras för-
stadier, utan att stöda hälsan, välbefinnandet och arbetsförmågan. Vid häl-
soundersökningar för barn och unga betonas uppföljning och stöd av uppväx-
ten och utvecklingen, för vuxna främjande av hälsan och funktionsförmågan 
samt stöd av arbetsförmågan.
Vi hoppas att den information och de erfarenheter som rapporten förmed-
lar är till nytta när man stakar ut riktlinjerna för screeningen, dess styrning och 
kvalitetskontroll i framtiden.
nyckelord: 
cancer, effekt, genomförande, likvärdighet, screening, styrning
9introdUction
The purpose of this publication is to describe how screening programmes 
are organised in Finland (the document describes the setting at the time of 
its completion in 2014), and how this system has been developed. Likewise, 
the publication examines how the provision of screening programmes 
is going to be steered following the social and health care reform. This 
publication also addresses health examinations, as these may also include 
screening examinations; in public debate, screening programmes and health 
examinations are often confused with one another.
The Ministry of Social Affairs and Health working group on screening 
has been responsible for drafting this publication. The Ministry appointed 
the working group to serve during the following terms: 16 October 2003–31 
December 2006, 1 January 2007–31 December 2007, 1 September 2008–31 
December 2010, and 1 January 2011–30 June 2015. The task of the working 
group has been to assess health care screening programmes and their methods, 
as well as to assess proposed screening tests to be included in a screening 
programme and their methods. The role of the working group was to act as 
a health policy adviser, rather than a specialist in matters of screening. The 
overall objective of the working group has been to ensure that Finland has 
proper screening programmes in place, taking into account morbidity and 
health care resources. 
The working group has focused on screening programmes that have a 
clearly-defined objective, which is to improve the prognosis of diseases. It is also 
valuable to engage in a discussion of values related to screening programmes, 
and the criteria used in defining them. This discussion must not be limited to 
the working group on screening, as there may be disagreeing opinions on the 
justifications for the screening tests coming from outside the working group 
as well.  Screening also inevitably poses some disadvantages – the seriousness 
of a certain disadvantage, and its significance for the individual and the 
society can vary widely. All of these factors must be taken into consideration 
when reaching an agreement on health care screening programmes and their 
content.
10
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1  froM tUBercUlosis to genetic 
screening PrograMMes:  
tHe History and PrinciPles  
of screening in finland
Marjukka Mäkelä, ilona autti-rämö
Screening is used to examine the general population, or a group within it, with the 
intention of discovering a specific disease or its precursor. Screening constitutes a 
part of preventive health care. A screening process includes the following: specifying 
the target group, providing individual advice and guidance, conducting and analysing 
screening tests, providing feedback, making referrals for further examination, and 
providing the necessary health services. The national screening programme includes 
screening programmes specified in the Government Decree on Screenings. In some 
cases, one test may be used to discover several different diseases, and several different 
screening-type examinations are usually conducted as part of health examinations.
In many ways, Finland has been a forerunner in population screening and in 
its governance. The National Board of Health used to be the one to regular-
ly issue national guidelines on a wide variety of measures involving health 
and diseases. Furthermore, these guidelines are based on expert opinions. 
Tuberculosis was historically the first disease in Finland to become subject to 
screening; it was, indeed, eventually eradicated – thanks to a comprehensive 
national health care system, advanced medical treatment, and screening pro-
grammes. 
In addition, prenatal monitoring has traditionally involved a wide variety 
of screening procedures for, among other things, infectious diseases. Screening 
pregnant women for syphilis was launched in the 1950s as a mandatory 
practice. HIV and Hepatitis B screening programmes tests began in 1990 
without having been imposed legislatively, until a 2004 Government decree 
made it mandatory to screen for all three infections. 
Cancer screening programmes began in the 1960s, under the supervision 
of the National Board of Health. During that time, cancer organisations first 
began screening for cervical cancer on a trial basis, and then expanded the 
practice nation-wide. Breast cancer screening was launched at the end of the 
1980s on a trial basis, which made it possible to examine how effective the 
screening actually was. The health impacts of screening for breast and cervical 
cancer were considered significant, and the responsibility for administering 
these screening tests was assigned to municipalities. These screening tests 
were put into law at the beginning of the 1990s.  
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The functions previously pertaining to the National Board of Health 
were in 1991 transferred to the newly formed National Agency for Welfare 
and Health, and then to the National Research and Development Centre 
for Welfare and Health (STAKES). Policies in the 1990s were based on 
information steering, i.e. providing information to the reach the planned 
target, as opposed to regulatory supervision, which would not be present in 
screening programmes for over the next ten years. 
The extensive right of municipalities to independently decide on how they 
wish to provide their health care services led to a situation in which screening 
programmes varied from one municipality to another. Concerning breast 
cancer in particular, some municipalities began to expand their screening 
onto age groups that were both older and younger than the age range of 50–
59 as specified in the legislation. Some municipalities also offered other types 
of screening programmes. The Ministry of Social Affairs and Health (MSAH) 
provided their input on how the provision of screening could be made equal. 
In 2000, the Ministry requested that the Finnish Office for Health Care 
Technology Assessment (Finohta), a unit within STAKES, should estimate 
the cost effectiveness of expanding breast cancer screening to include women 
between the ages of 60–69. From a societal standpoint, the impact on older 
age groups was found to be just as positive as on younger groups.
After an extensive public debate on Finohta’s estimate, the Ministry of 
Social Affairs and Health decided to expand breast cancer screening tests; 
this decision took effect at the beginning of 2007. At the same time, there 
was an ongoing debate on the expansion of screening for neonatal metabolic 
disorders in a way which would include new disease groups. The debate also 
regarded guiding screening programmes for foetal structural and chromosomal 
abnormalities. It was considered if screening programmes could be steered in 
a more streamlined manner than with legislation – so that it would be possible 
to observe changes in the knowledge base or methods more flexibly. It was 
subsequently decided that screening regulations would be issued by decree. 
In October 2003, the Ministry of Social Affairs and Health established a 
working group to assess screening programmes. Representatives from bodies 
such as the Association of Finnish Local and Regional Authorities, Finnish 
Cancer Registry, Mass Screening Registry and Radiation and Nuclear Safety 
Authority (STUK), as well as from the National Institute for Health and 
Welfare and STAKES, were invited to participate in the working group. Similar 
centralised steering is used in some countries, such as the Netherlands and the 
United States. The model for Finnish operating methods was borrowed in 
particular from those applied0 by the UK National Screening Committee 
(UK NSC).
The working group on screening initially agreed upon the criteria for 
assessing screening programmes – these are based on the ten principles of 
screening published by the World Health Organization (WHO) in 1968. 
These so called Wilson and Jungner criteria for screening were supplemented 
15
with additional items adopted from the Danish Council of Ethics (Table 1). 
The criteria were tested and their order was changed so as to make the 
assessment more logical, at the time when the working group was deliberating 
over the initiation of colon cancer screening tests in 2003. 
The claims made in the criteria are very different in nature. Many of the 
claims can be supported by reliable data based on research, while others 
can only be supported by second-hand data obtained, for example, through 
modelling. The importance of the criteria varies depending on the disease 
targeted by screening, and on the situation. When considering to launch 
a screening programme, it is important to define the health goals and to 
determine what kind of evidence already exists for each criterion, as well as 
what additional information can be obtained by, for example, a pilot study.
The working group has compiled a list of the screening tests, screening-
type examinations and proposed screening tests to be carried out in Finland. 
The screening programmes subject to assessment have been divided into five 
categories: prenatal screening, screening tests for children and young people, 
those for persons of working age, cancer screening programmes and others. 
Over 60 diseases or health problems have been listed as possible screening 
targets, but only a few of these have been addressed in a comprehensive way. 
For example, no opinion has been issued on genetic screening programmes. In 
each category, new diseases considered to be important have been assessed in 
order to determine their inclusion in the screening programme. Assessments 
have occasionally addressed, for example, the area covered by working groups 
on maternity care or infectious diseases. Based on the recommendation by the 
working group on screening, the Ministry of Social Affairs and Health may 
decide that screening is not justified, or it may initiate a screening programme 
either under a Government decree or, at a lower level, by sending a letter of 
authority to municipalities. The decisions are based both on information and 
on an open public debate.
The assessment criteria have helped in identifying problem areas in 
screening programmes, and drawn attention to lack of available information. 
Even minor harms caused by a screening programme are taken into 
consideration in impact assessments, and in the provision of information to 
the public at large. Not all screening programmes which have gone through 
the assessment process have subsequently been initiated, even though their 
cost effectiveness, compared to other health care activities, would have been 
reasonable. However, not one active screening programme has yet been 
discontinued or downsized. 
The boundary between screening programmes and health examinations 
is difficult to define and is often on a sliding scale. Placed at one extreme 
are the screening tests designed specifically for discovering a single disease, 
such as cancer screening programmes. On the other hand, some standard, 
screening-type functions, such as monitoring the height and weight of 
children, may be used to identify several different diseases. There are also 
16
screening-type procedures in the Finnish health care system, but treating 
problems identified by these would require extensive system-wide changes. 
An example is screening for prenatal depression, which has been tried out in 
some municipalities, but discontinued when many more suspected cases were 
identified than could be treated with available resources. 
With the working group on screening, the national steering of screening 
has been functioning well. Proponents of screening have waited for long time 
periods, sometimes years, to recieve the group’s comments. No “opportunistic” 
screening programmes have been initiated, and the screening programmes 
regulated by decree are fairly comprehensive. There is still a need for national 
guidance of screening programmes, as it is necessary to ensure equality and 
the appropriate implementation of limited resources. An important matter 
to keep in mind for the future is to organise a continuous quality control 
of already existing screening programmes. This is currently only done for 
cancer. A lack of screening registers for screening programmes other than 
those concerning cancer makes quality control and national overview nearly 
impossible.
Table 1. Assessment criteria drawn by the working group on screening. The 
original numbering of the wHO and Danish Council of Ethics (T) criteria are 
enclosed in parentheses. 
1.  The condition sought should be an important health problem. (wHO1)
2.  There should be a recognizable latent or early symptomatic stage. (wHO4)
3.  The natural history of the condition, including development from latent to declared 
disease, should be adequately understood. (wHO7)
4.  There should be a suitable test or examination (wHO5), with an evaluatedvalidity of 
the testing system (T11a), technical efficiency (T11b), and predictive value of test results 
(T11c).
5.  The test should be acceptable to the population. (wHO6)
6.  Prior to beginning screening, an evaluation must have been made of the ethical and 
psychological consequences for the examinees (T12a), stigmatisation (T12b), and the 
consequences of “false positive” and “false negative” test results (T12c).
7.  There should be an agreed policy on whom to treat as patients. (wHO8)
8.  There should be an accepted treatment for patients with recognized disease. (wHO2)
9.  Facilities for diagnosis and treatment should be available. (wHO3)
10.  The screening organisation has been explained in detail (T14), particularly the national 
and regional level (T14a), quality control and registration of results (T14b,c), provision 
of information to the target group (T14e), patient placement within the organisation 
(triage) (T14d), personnel training (T14f) and providing information and advice on test 
results. (T14g).
11.  The research and treatment costs incurred by screening have been described. (wHO9)
12.  The impact of screening has been assessed. (T13)
13. Case-finding should be a continuing process and not a “once and for all” project. 
(wHO10)
14.  The cost of case-finding (including diagnosis and treatment of patients diagnosed) should 
be economically balanced in relation to possible expenditure on medical care as a whole. 
(wHO9)
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2 steering and ProVision  
of screening PrograMMes
Marjukka Mäkelä, Päivi Koivuranta-Vaara, ritva Bly, Kirsi 
ruuhonen, taru Haula, neill Booth, Ulla saalasti-Koskinen
Screening programmes are steered at the national level both by standards and less-
binding information-based guidance. Apart from screening programmes which are 
regulated by decree, screening providers are fairly free to choose which screening 
programmes they wish to offer and which screening methods to employ. In many 
countries, in order to ensure equality, the degree of national steering has been 
gradually increasing for screening of individual diseases. Extensive public discussion on 
the goals and impacts of screening forms a solid foundation for steering.
2.1  screening PrograMMes carried oUt in 
accordance witH tHe screening decree 
As stated in the Health Care Act: “local authorities shall arrange screening within 
their area in such a way that complies with national screening programmes.” 
The following are specified in the Screening Decree: “Breast cancer screening 
every 20–26 months for women aged between 50 and 69”, “cervical cancer 
screening every five years for women aged between 30 and 60”, and prenatal 
screening tests for pregnant women. Prenatal screening tests include “a general 
early pregnancy ultrasound scan”, “detection of chromosomal abnormalities” 
and “an ultrasound scan for the detection of severe structural abnormalities”. 
Tests for chromosomal abnormalities are performed during early pregnancy 
– the abnormalities can be found through a combined screening (a blood 
screen test and neck oedema measurement during a general ultrasound scan), 
or through a maternal serum screening during the second trimester of the 
pregnancy. Tests for severe structural abnormalities are performed during a 
general ultrasound scan at the midway point of the pregnancy.
2.2 ProVision of screening PrograMMes
Screening programmes are a part of promoting health and welfare, as laid 
down in the Health Care Act. Municipalities can also offer their residents 
screening programmes other than the ones mentioned in the Decree. The 
decision on providing screening programmes is made when municipalities 
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belonging to the same hospital district draft a health care provision plan, 
which outlines the provision of primary health care services, including 
screening programmes. Municipalities and joint municipal authorities can co-
operate with one another, and with hospital districts, in the procurement and 
provision of screening services. The provision plan should focus on ensuring 
a uniform and comprehensive offer and quality of screening services, where 
screening programmes specified in the Decree and any other screening 
programmes are concerned.
Under the Act on Planning and Government Grants for Social Welfare and 
Health Care (733/1992), a municipality may provide social and health care 
services by itself, or by procuring services from the State, another municipality, 
a joint municipality or another public (e.g. hospital district) or private 
service provider. Today, particularly where cancer screening programmes 
are concerned, these services are primarily outsourced. Responsibility for 
screening as a whole and its quality remains with the municipality, regardless 
of how screening programmes are provided. 
In 2013, the Ministry of Social Affairs and Health working group on 
screening drafted  Syöpäseulontapalvelujen hankintaopas (Cancer Screening 
Services Procurement Guide), which is available on the website of the 
Association of Finnish Local and Regional Authorities. It contains information 
on the legislation concerning screening programmes and procurements, and 
sets out quality criteria for the provision of screening services. 
2.3  screening PrograMMe and  
screening Process
Under the Screening Decree currently in effect, each municipality is required 
to draft a screening programme in advance each year. The breast cancer 
screening programme is given as an example below; it is based on a precisely 
defined set of guidelines, which can be used as a model for other screening 
programmes. It should also be discussed whether it will be necessary to 
determine the national body which will inspect all municipal screening 
programmes in advance.
Breast cancer screening is governed by rules and regulations from several 
institutions.The Screening Decree lays down the minimum requirements for 
breast cancer screening. The Radiation and Nuclear Safety Authority (STUK) 
has issued a guideline on the quality assurance requirements concerning 
the radiation safety of mammography. The Decree of the Ministry of Social 
Affairs and Health on the medical use of radiation stipulates that a breast 
cancer screening programme inspected by STUK must be drafted before any 
screening is started. The programme must specify:
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1)   The purpose of screening and the target population groups;
2)   The party providing the screening services and the regional scope of 
the screening;
3)   The suitability of the screening method;
4)   The radiological equipment used in the screening and its suitability;
5)   The personnel who are to carry out procedures involving radiation 
exposure, and their training;
6)  Physicians who interpret the screening results, issue statements on 
them, and are responsible for confirmation examinations;
7)  Quality assurance programme;
8)  Monitoring of the equipment’s condition and performance;
9)  Plan for implementing clinical audits;
10)  Registering and reporting of screening data and results. 
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Figure 1. Cancer screening process
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The screening process (Figure 1) is a chain of several functions that are 
jointly carried out by multiple actors. According to the Screening Decree, the 
screening process includes
– Specifying of the target group 
– Providing individual advice and guidance 
– Taking and analysing screening images or samples 
– Providing information on screening results 
–  Referring to tertiary care examinations and providing the necessary 
health services.
Quality requirements apply to the entire process, from population 
sampling, treatment referralfor a diagnosed disease, to providing results of the 
treatment and registering data. 
The municipality is responsible for screening as a whole. The screening 
programme must include an appropriate quality management and quality 
assurance procedure, which can be used to assess the quality of the entire 
screening process and the reliability of screening tests, continuously and on 
a regular basis. The quality requirements apply to in-house functions as well 
as any outsourced functions. Even though high technical quality of screening 
and expertise of the personnel conducting it are essential, they alone are not 
sufficient factors to ensure the effectiveness of the screening. A supervisor 
in the municipality must be assigned to each screening, so as to ensure the 
overall quality of the screening process.
Using a register to collect screening data makes it possible to assess the 
impact of the screening, and this also constitutes a part of quality control. 
For example the Mass Screening Registry of the Finnish Cancer Registry has 
been collecting data since the 1960s. There is, however, no equivalent national 
register for prenatal screening programmes. In 2009, the Ministry of Social 
Affairs and Health working group on the screening of foetal abnormalities 
proposed a national screening register, to be established as a sub-register of 
the National Institute for Health and Welfare birth register. However, the 
necessary resources have not yet been found for creating this register. The 
local monitoring of prenatal screening programmes is made complicated by 
the fact that neonatal data cannot always be sent directly to the screening unit 
(maternity clinic) due to privacy protection. This, coupled with the lack of a 
national prenatal screening register, makes it practically impossible to ensure 
a process of quality assurance.  
2.4 Monitoring and steering 
Regional State Administrative Agencies steer and monitor public health work 
within their respective areas, which also includes screening. The National 
Supervisory Authority for Welfare and Health (Valvira) steers the operations 
of the Regional State Administrative Agencies and monitors public health 
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work, especially in matters that are fundamentally important or far-reaching. 
Regional State Administrative Authorities and Valvira are also responsible 
for monitoring private health care. Thus, performing supervision of the 
municipality responsible for screening, and the private providers of screening 
services, is the duty of the above authorities. 
The National Institute for Health and Welfare (THL) and STUK, among 
others, serve as institutions which provide expert opinion. Together with 
other actors in the field, THL monitors and assesses screening programmes 
currently underway and the methods the programmes employ. The THL 
unit Finohta submits assessment reports to the Ministry of Social Affairs and 
Health so as to support the Ministry’s decision-making. These reports contain 
assessments of, for example, the effectiveness, cost-effectiveness, and ethical 
and organisational factors concerning screening. In addition to this, Finohta 
supports municipalities in conducting screening programmes by, for example, 
producing support material related to screening. STUK monitors the safety of 
radiation use, and issues radiation safety guidelines.
Under the Decree on National Personal Data Registers for Health Care 
(774/1989), health care authorities and institutions must submit all cancer 
screening invitation and inspection data to the THL Cancer Registry, the 
technical maintenance of which is the responsibility of the Cancer Society 
of Finland. The Mass Screening Registry, which is part of the Finnish Cancer 
Registry, monitors and assesses cancer screening programmes in Finland at 
the national level. The Mass Screening Registry collects screening data at the 
individual level from the level of whole Finland, compiles national screening 
statistics and monitors cancer screening processes and scientific studies in the 
field. 
Assessment of the cancer screening process is ultimately based on the 
measure of its effectiveness (cancer mortality and incidence). For the purpose 
of assessment, the Mass Screening Registry also collects data on new cases 
of cancer and on cancer deaths in the target screening population. With the 
exception of cancer screening programmes, the effectiveness of screening 
programmes is not systematically monitored in Finland. 
2.5  screening costs and financial 
assessMent 
According to the assessment criteria of the working group on screening, the 
examination and treatment costs of a new screening programme should be 
specified, and its total costs should be reasonable compared to other health 
care services (Table 1, points 11 and 14). A financial assessment compares 
the health and cost impacts of alternative methods. Financial profitability 
is affected by, for example, the extent, measurement, and assessment of 
cost-benefit impacts. In broad terms, screening is examined firstly from the 
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diagnostic and treatment process, which begins with an invitation, all the way 
to the final health outcomes. 
Viable information on screening costs and impacts, that is suitable 
for Finnish conditions, is needed in decision-making When it comes to 
new screening methods in particular, it is often difficult to quickly obtain 
information, which forces the personnel to make assumptions. Assessing the 
financial profitability of screening programmes involves several key factors 
related to, for example, the assessment perspective and the length of the 
period under review. These factors should be taken into consideration when 
interpreting the results of financial assessment and the applicability of the 
assessment to decision-making processes. As is to be expected, the working 
group on screening has also made use of expertise in health economics.
2.6  Use of radiation in screening 
PrograMMes and HealtH exaMinations 
X-rays and other examinations involving radiation are included in many 
screening programmes and health examinations. In such cases, non-
symptomatic people are exposed to radiation. The benefit(s) gained from the 
examination must then outweigh the harm(s) or additional risk(s) it poses. 
The justification for radiation exposure should be assessed and explained in 
advance. When a health examination requires a procedure involving radiation 
exposure, the referring physician assesses the justification for the procedure. 
The referral must clearly state the examination indication. The performance 
of procedures which involve radiation exposure repeatedly and routinely, 
without assessing their need, is not in accordance with the principle for 
justification.
Screening tests conducted in accordance with the national screening 
programme are provided by invitation, not referral. At the moment, the only 
procedure involving exposure to radiation that is included in the national 
screening programme is mammography, which is used for the early detection 
of breast cancer. Mammography, or other x-ray examinations performed 
as a part of a screening programme, may not be performed during a health 
examination on a physician’s referral.
The Screening Decree specifies which screening tests are included in the 
national screening programme. If the screening provider wants to expand 
the target group of these screening tests, or offer the public other screening 
tests, this must be justified separately and a plan for it must be submitted 
to the National Institute for Health and Welfare for assessment. Screening 
can be approved if it is deemed justifiable and if the public health benefit 
it provides outweighs the overall harm it may pose. A screening programme 
for screening tests which expose patients/individuals to radiation must be 
submitted to STUK for inspection before any screening tests are carried 
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out. An amendment to existing regulations has been proposed, stating that 
screening tests involving radiation exposure, but which are not a part of the 
national screening programme, would require a statement from STUK on the 
use of radiation. In the future, before beginning any screening programmes, 
the screening provider must also submit an assessment concerning the 
justification for screening tests which involve radiation to THL for inspection. 
The National Institute for Health and Welfare issues a statement to the 
screening provider within three months on whether the public health benefit 
offered by the screening outweighs the overall harm it may pose. If the 
screening is not deemed justifiable, it may not be initiated.
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3 PreParation and iMPleMentation 
of new screening – exaMPle: 
Prenatal screening PrograMMes 
Marjukka Mäkelä, Jaana leipälä, Ulla saalasti-Koskinen,  
ilona autti-rämö
Adding a new screening test to the national screening programme requires a great deal 
of preparation. Public debate and effective implementation promote the acceptability 
of the screening and establish a basis for common practices. They also increase the 
involvement of the target population.
Each screening should meet the requirements specified in Table 1 so as to 
justify their use. However, screening and diagnostic methods, as well as the 
desired health outcomes, vary widely from one screening procedure to another. 
Although there is, because of these factors, a need for national steering, the 
steering must be specifically tailored to each screening. This chapter will use 
examples to describe the challenges facing the implementation of a new 
screening procedure.
Prior to regulatory steering, screening programmes for the detection of 
structural and chromosomal abnormalities in the foetus were conducted in 
different ways by different municipalities. The national working group on 
family planning and maternity care made recommendations on the subject in 
1999, but the practices remained varied. However, upon further development 
of screening methods, more binding national steering became necessary. 
Foetal abnormalities are screened for using an ultrasound and maternal 
blood samples. Through the obtained results, it is possible to identify some 
of the structural and chromosomal abnormalities in a foetus. Many of the 
abnormal findings require that the child be born in a unit that is well-
equipped, in order to provide proper and necessary treatment. Indeed, one of 
the goals for prenatal screening programmes is to provide proper care during 
pregnancy and birth in order to ensure the health of the child. 
Screening programmes can also be used to identify abnormalities that 
will result in a severe handicap that cannot be treated. In such cases, the 
information provided by the screening allows the mother to make an informed 
decision on whether to continue or terminate the pregnancy. However, not all 
abnormalities can be identified by screening - nearly all severe deformations 
of the brain can be identified by an ultrasound scan, but it can detect, e.g., 
only some of the congenital heart defects. 
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3.1  deVeloPMent of Prenatal screening 
MetHods
In Finland, prenatal screening began in the 1970s, when it was found that 
an amniocentesis (taken in weeks 14–15 of the pregnancy) can be used to 
detect chromosomal abnormalities, such as Down’s syndrome. In the 1980s, 
chorionic villus sampling (CVS) of the placenta during weeks 11–12 of the 
pregnancy accelerated the detection of chromosomal abnormalities. Both 
procedures involve the risk of miscarriage, which is just as high for foetuses 
with chromosomal abnormalities as it is for healthy foetuses. Initially, 
screening programmes were offered to older pregnant women, as the risk of 
abnormalities increases with the mother’s age. The age limit was set by each 
municipality, ranging between the ages of 35 and 40. 
Ultrasound scans were first used to determine the size and number of 
foetuses, and the location of the placenta, so that the delivery method and 
date could be determined. Methods have since became more advanced and, 
in the 1990s, the increased risk of chromosomal abnormalities could already 
be identified in the early stages of pregnancy. This meant that it was possible 
to limit invasive procedures only to pregnancies that exceeded this risk 
threshold. It also became easier to detect deformities during the pregnancy. 
At the beginning of the 2000s, chromosomal abnormalities were present in 
an average of 0.6% of newborns and major deformities in 2-3% of newborns.
At the turn of the millennium, there was an increase in the number of 
older women having babies, and pregnant women’s access to information 
on various screening methods improved. The wide variety of screening 
practices in different municipalities led to a situation wherein the Finnish 
Gynecological Association requested an assessment of screening programmes 
for abnormalities in foetuses. Finohta’s assessment report on this topic was 
published in 2005, sparking extensive public debate on prenatal screening.
An early pregnancy ultrasound scan is performed in order to ensure that 
the foetus is alive, as well as to determine the number of foetuses and the 
estimated gestation period. Some severe structural abnormalities, such as 
the lack of a brain, can be seen at this stage, even though looking for these 
is not the primary objective. If parents want to screen for chromosomal 
abnormalities in the foetus, a neck oedema measurement is taken during the 
early pregnancy ultrasound. A neck oedema measurement must be discussed 
before it can be performed. 
Chromosomal abnormalities are screened by means of a neck oedema 
measurement and the levels of two maternal serum markers, in relation to 
the mother’s age and gestation period. This provides a risk classification, 
which indicates the likelihood of chromosomal abnormalities in the foetus. 
In approximately five out of every one hundred women, the result of this 
combination screening is abnormal, i.e. the probability of Down’s syndrome 
is greater than 1:250. If the combination screening is not performed in time, 
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the likelihood of chromosomal abnormalities can be determined with a serum 
screening taken a few weeks later. A serum screening alone, however, is not as 
sensitive and precise as a combination screening.
The combination or serum screening does not provide a definite diagnosis 
of chromosomal abnormalities. The method can produce a false positive result 
as well as a false negative, failing to detect an actual abnormality. If the mother 
so desires, information on an elevated risk for chromosomal abnormalities will 
be followed by tertiary care examinations, i.e. a CVS or amniocentesis for 
chromosomal examination.
A structural ultrasound examination can be used mid-term to identify 
any severe structural abnormalities in the foetus. At this time, it is possible 
to provide any necessary tertiary care examinations, estimate the foetal 
prognosis and discuss alternatives with the mother. It is possible to terminate 
the pregnancy based on the condition of the foetus before the end of week 24. 
The mother can also choose to have a structural ultrasound later, in weeks 24–
28, when termination is no longer an option. In this case, the objective of the 
examination is primarily to identify abnormalities which can be addressed, 
thus improving the prognosis of the child by means of closely monitoring the 
pregnancy and referring the mother to a fully-equipped hospital. 
3.2 dialogUe on inforMation and ValUes
The prenatal screening assessment report provided the impetus for including 
screening procedures for foetal abnormalities in the Screening Decree. The 
report presented the effectiveness and risks of different screening methods, 
and addressed ethical issues concerning prenatal screening. It was possible 
to use new methods which detect numerous health problems, whose 
consequences to the foetus and mother varied widely (Table 2). Prior to the 
report’s publication, the Ministry of Social Affairs and Health organised a 
public forum which addressed screening alternatives, information on them, 
the freedom of choice, issues concerning the termination of pregnancy due to 
foetal abnormalities, and a national organisation for screening programmes. 
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Table 2. Abnormalities detected in ultrasound examinations, risks associated 
with them and possible measures
Abnormality Risk Possible measures
Multiple pregnancy Premature birth Rest and delivery method 
planning 
Placenta praevia bleeding risk, birth obstruction Planned caesarean section
Some chromosomal 
abnormalities
Still birth Frequent monitoring; abortion
Development disorder 
of the urethra 
kidney damage Foetal surgery
Anencephaly Neonatal death Termination of pregnancy
Major heart defects Infant death Heart surgery immediately 
after birth
Based on the report and public debate on prenatal screening, as well as 
on subject-related expert opinions, the Ministry of Social Affairs and Health 
determined that there was a need to standardise screening practices. This 
was done by drafting the Screening Decree – onto which breast and cervical 
cancer screening regulations were also transferred. 
The public debate on screening practices provided a wide range of views, 
and heard the opinions of both proponents and opponents of screening. 
Namely, invaluable views were offered by women who had terminated their 
pregnancies – both those who regretted their decision and those who were 
satisfied with it – and by professionals who performed screening programmes 
and abortions. A common denominator was the importance of having sufficient 
foreknowledge of the screening objectives, and the freedom of choice with 
regard to the screening programme. Today, it is possible to choose the time of 
screening so that any detected abnormality can be taken into consideration in 
the birth, but termination is no longer an option. 
A comprehensive body of information for expecting families and screening 
providers was produced in accompaniment to the legislation, and numerous 
professionals involved in the practical aspects of screening participated in 
its compilation. Health care professionals also received training on how to 
converse with pregnant women during different screening situations. The 
public debate provided excellent information on how to practice screening 
programmes.
3.3 effectiVe Practices
The screening process begins with identifying the target group; for prenatal 
screening, this is done in maternity clinics. Although blood samples are generally 
taken at maternity clinics, an ultrasound examination is taken at a prenatal 
clinic or another screening unit. If necessary, tertiary care examinations are 
conducted at a university hospital, to which pregnant women are referred by 
the screening unit. 
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Concentrating screening programmes to sufficiently large units ensures 
that the employed screening methods are uniform and of a high standard. 
Ultrasound examinations are usually performed by a trained ultrasound 
nurse. A good practice would be for a nurse to be able to consult a physician 
immediately in the case of any suspicion of an abnormality in the ultrasound 
examination. 
Providing unbiased and understandable information on screening is vital, so 
that people being called in for screening can participate in making an informed 
decision. The screening provider must provide information on the advantages 
and disadvantages of screening or of tertiary care examinations, as well as 
describe the various stages of the screening. Providing clear information as 
early as possible in the pregnancy is essential. Screening providers (maternity 
clinic, screening unit and tertiary care unit) must agree on a uniform provision 
of information. 
The sharing of information between providers is also important. Computer 
system incompatibility and privacy practices can hinder the flow of information 
between providers. Information on abnormal findings should flow smoothly 
from the maternity clinic to the prenatal clinic, and vice versa. Information 
from the maternity hospital is needed at the prenatal clinic and the maternity 
clinic. Information flow is also a part of quality assurance, as the newborn’s 
condition indicates the end result of prenatal screening programmes. The 
objective is to establish an electronic patient information system that covers 
all aspects of prenatal screening programmes, and supports the effective and 
timely provision of information. The new electronic maternity card makes it 
possible for pregnant women to read information from and enter it into the 
system. 
Each municipality is responsible for providing its residents with 
screening programmes laid down in the Decree. According to the latest 
report, municipalities conduct prenatal screening programmes fairly 
comprehensively (Table 3). However, in 2013, screening programmes for 
structural abnormalities conducted after week 24 were only offered in one 
out of every two municipalities. The three-year transitional period specified 
in the Screening Decree was thus not sufficient for the full implementation 
of the Decree since it entered into force in 2010. 
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Table 3. Provision of prenatal screening programmes in municipalities in 2007, 
2009 and 2013
Screening for abnormalities in foetuses 2007 2009 2013
General early pregnancy ultrasound 74% 92% 91%
Combination screening for chromosomal abnormalities 58% 87% 99%
Mid-term serum screening 10% 62% 64%
Screening for structural abnormalities in weeks 18–21 77% 88% 97%
Screening for structural abnormalities after week 24 8% 51% 51%
3.4  sUPPort and Monitoring to  
ensUre qUality 
Legislation is not enough to implement a new national screening programme. 
What is needed is concrete support for screening providers, particularly in 
regions where screening was not offered previously. The different phases in 
the implementation of prenatal screening are listed in Table 4.
To support the implementation of these screening programmes, Finohta 
planned training and provided information in co-operation with the expert 
working group on screening. A general guidebook on prenatal screening 
programmes was produced for all pregnant women, and a separate guidebook 
on tertiary care examinations was produced for those referred to participate in 
the examinations. Training for trainers of prenatal screening professionals was 
arranged, and a training package was introduced for local training sessions. An 
interaction guidebook provided staff with advice on how prenatal screening 
programmes and their results should be discussed with pregnant women. Risk 
assessment cards for determining the risk of chromosomal abnormalities in 
women of different ages were also made in support to screening. All materials 
were compiled on the National Institute for Health and Welfare website, 
where they are available free of charge (www.thl.fi/seulonnat). 
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Table 4. Support phases for implementation of prenatal screening programmes
Year Provider Result
1999 STAkES Expert Group on Family 
Planning and Maternity Care
Recommendation on screening 
programmes and co-operation in 
maternity care, including structural 
and chromosomal abnormalities in 
foetuses
2003 Stadia (later Metropolia) Initiation of a training programme 
for ultrasound nurses in prenatal 
screening
2003 Ministry of Social Affairs and Health Establishment of the working group 
on screening
2003 board of Directors of the Finnish 
Gynecological Association 
Request for examining the 
effectiveness of prenatal screening
2005 Finohta/STAkES Assessment report on the 
effectiveness of prenatal screening
2005 Ministry of Social Affairs and Health Open seminar on the effects of 
prenatal screening and on their 
alternatives
2006 Ministry of Social Affairs and Health Prenatal screening programmes made 
mandatory under the Screening 
Decree
2007–
2009 
National expert working group for 
supporting the implementation of 
prenatal screening programmes (co-
ordinated by Finohta/STAkES)
For professionals: training and training 
package, interaction guidebook, risk 
assessment cards, website. General 
and tertiary care examinations 
guidebook for families 
2008 Expert working group supporting 
implementation of the Screening 
Decree (Ministry of Social Affairs and 
Health)
MSAH Reports Series report, which 
includes prenatal screening quality 
requirements 
2010 Assessment of the Finohta-coordinated 
national expert working group 
Assessment report on 
implementation, prepared by the 
National Institute for Health and 
welfare
The expert working group’s activities and results were found to be 
beneficial in assessing support for the implementation of prenatal screening 
programmes, although there was some variation in the adoption of guidelines. 
Municipalities used the provided material to support their work; they did 
this either by adopting the material as such, or as a template for creating 
guidelines tailored to local conditions. Guidebooks aimed at pregnant women 
have been among the most ordered products issued by the National Institute 
for Health and Welfare for years. 
The Ministry of Social Affairs and Health appointed an expert working group 
to promote a high quality of screening programmes for foetal abnormalities. 
The purpose of this action was also to promote nationally standardised 
prenatal screening programmes. The group outlined quality requirements for 
conducting screening examinations, as well as the equipment and training 
required for screening. For example, a person conducting structural ultrasound 
examinations must participate in two ultrasound training programmes and 
perform at least 500 examinations each year. 
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A new screening programme usually requires the procurement of new 
equipment and the training of new professionals. Clinical ultrasound nurses 
specialising in prenatal screening procedures are trained at Metropolia 
University of Applied Sciences in Helsinki. Most of the participants in the 
degree programme have qualifications in midwifery or public health nursing 
as basic training. Furthermore, screening units provide in-service training to 
nurses. 
The Ministry of Social Affairs and Health working group has listed factors 
important in monitoring of quality and effectiveness, and has also presented 
alternatives to the process of monitoring screening quality. The working 
group felt that assessment of prenatal screening programmes would be most 
effective through the utilisation of a national screening registry. This would 
require the collection of tagged personal data and combined information on 
the mother and her child. The group proposed that a screening registry be 
formed as a part of the birth registry. This has not yet been realised – screening 
data is collected only at the regional level and in different ways. The problem 
is that information on the newborns cannot be transferred to the screening 
location due to privacy protection. This makes it difficult to provide quality 
assurance and determine the overall impact of screening. 
3.5 eqUality and etHical issUes 
The intention behind supporting the implementation of prenatal screening 
is that pregnant women can have equal access to screening services. Even 
though municipalities offer prenatal screening comprehensively, structural 
ultrasound examinations conducted after week 24 are only available in one out 
of every two municipalities. Before participating in a screening procedure, the 
pregnant woman must understand what screening is and what it might lead 
to. Communicating in the pregnant woman’s native language is essential and, 
if necessary, she should have an interpreter present to explain the screening 
results in understandable terms. Although screening programmes are free of 
charge, tertiary care examinations usually involve a fee that is equal to the 
standard outpatient clinic fee.
Screening principles require that the procedure only looks for treatable 
problems,  the treatment should promote health and be ethically acceptable. 
In prenatal screening programmes, these requirements are not always met. A 
single ultrasound examination can be used to identify a number of different 
health problems, some of which are not treatable. Screening can thus be used 
as the basis for terminating a pregnancy, if the expecting mother so chooses. 
Consequently, it is absolutely necessary for participation in the screening 
programme to be voluntary, so as to avoid any woman with a negative attitude 
toward abortion being forced into an impossible situation. Another specific 
ethical issue is that the pregnant woman ultimately makes the decision on 
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whether to terminate the pregnancy or to take another course of action on 
behalf of the foetus. 
These issues can be addressed considering the different views and values 
people might have when participating in screening programmes. It is crucial 
to obtain sufficient information before participating in a screening. In Finland, 
a woman coming in for a screening procedure can state that she does not want 
to know about any abnormalities, but rather only the number of foetuses 
and gestation period. If in such a situation screening programmes reveal a 
significant abnormality, the screening venue should have clearly defined 
procedures in place for recording the result and registering information 
about it. The pregnant woman may also choose to schedule the structural 
ultrasound examination at a time when it is no longer possible to terminate 
the pregnancy on the basis of a severe foetal abnormality. 
The possible harm of prenatal screening examinations in tertiary care 
(CVS and amniocentesis) is the risk of miscarriage: 1–2 pregnancies out 
of one hundred will end in miscarriage due to these examinations. The 
pregnant woman must weigh the possible risk of miscarriage and consider 
what the likelihood of chromosomal abnormalities would be at her age. 
Since most women do participate in tertiary care examinations, refraining 
from participation requires more information and personal deliberation on 
the patient’s part. In this situation, the unbiased information provided by a 
healthcare professional is essential.
3.6 iMPleMentation of screening continUes 
The need for standardising prenatal screening programmes increased 
significantly at the beginning of the 2000s. At that time, prenatal screening 
programmes were offered by municipalities in different ways, with some 
not offering any screening programmes at all. The assessment report on the 
effectiveness of prenatal screening programmes, a public debate on values, 
and consultation of experts formed the basis for legislation. Municipalities 
were given three years to implement the new screening arrangements. During 
this time, municipalities were given support in a variety of ways: training 
and guides for professionals, brochures for pregnant women and quality 
recommendations for screening providers. According to the assessment, the 
measures were successful in supporting implementation. Most of the material 
produced was considered useful and was adopted. 
A key factor in monitoring the effectiveness and quality of screening 
programmes is the screening registry. There is still no national prenatal screening 
registry – data is collected by different means in each region. Due to the lack 
of a registry, it would be important to examine how screening programmes are 
conducted at the regional level, and how quality management is organised. In 
this respect there is still ongoing monitoring of the implementation. 
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4 screening assessMent and 
decision-MaKing
Marjukka Mäkelä, Ulla saalasti-Koskinen, taru Haula, neill 
Booth, outi lyytikäinen, Jaana leipälä, ilona autti-rämö
Screening programmes should provide ample health benefits, so that offering them 
is justifiable from a public health perspective. Therefore, there must be a clear 
understanding of the benefits, costs and societal impacts before a decision on 
launching a new screening programme is made. Many screening services have been 
launched without any specific guidance, on the initiative of health care professionals. 
The effectiveness of some mandatory screening programmes has also been assessed 
retroactively in Finland. In some cases, screening assessments reveal that there would 
be no real benefit to launching a service.
In Finland, only a few screening programmes are regulated by law. However, 
rapid changes in the needs posed by healthcare and health technologies have 
led to the need for a more flexible approach to regulation. This is why, in 
2006, regulation was moved to the purview of the Screening Decree, which 
sets the guidelines for cervical and breast cancer screening as well as for pre-
natal screening. One of the conditions for regulation is that the State supports 
assigning a new mandate to municipalities through central government trans-
fers. 
A more streamlined information steering approach is used in the steering 
of most types of screening. For example, it would not be appropriate to 
include fast-changing technical methods in the Decree. In such cases, health 
care development should be steered and supported by other means, so that 
screening can be offered equally throughout the country, implemented 
effectively and its impacts assessed in a timely manner. 
New screening programmes assessed during the years that the working 
group was running were quite comprehensive. Finohta’s assessment reports 
describe the health advantages, disadvantages and costs of screening 
programmes based on a systematic review of literature. Thought was also 
given to social and ethical aspects, and practical implementation. Although 
the impact of some screening programmes can already be monitored, for 
example, by using the Infectious Diseases or Cancer Registry, a dedicated 
monitoring system should be developed for some of the new screening 
programmes. 
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4.1 early Pregnancy infection screening
Maternity clinics have conducted mandatory syphilis screening since the 
1950s. Hepatitis B and HIV screening programmes were gradually introduced 
in the 1990s without regulatory steering. These infections can be passed from 
the mother to the foetus, thus threatening the health of the child. Screening 
methods can be used to prevent the infection being passed onto the foetus, 
if the mother and child receive treatment early enough. In 2004, screening 
for all three diseases was mandated under the Decree for vaccinations and 
screening for infectious diseases during pregnancy.
The effectiveness and costs of screening for infectious diseases during 
pregnancy were assessed in a 2014 Finohta report. The current screening 
programme was estimated to prevent 28 neonatal infections each year: three 
syphilis infections, four HIV infections and twenty-one Hepatitis B infections, 
consequently preventing the death of one child, the disabling of two children 
and lifelong HIV treatment of four children. The annual cost of the early 
pregnancy screening programme was estimated to be approximately EUR 1 
million, with the cost of an individual prevented infection being an estimated 
EUR 12,000–147,000. 
The assessment showed that the early pregnancy screening programme 
and its follow-up measures are still not being implemented in a uniform way. 
The quality management of screening would require standardised guidelines 
and systematic national monitoring. Thus, regulatory steering alone has not 
been enough to ensure uniform implementation. 
4.2  strePtococcUs screening dUring 
Pregnancy 
Group B Streptococcus (GBS) causes a severe infection, which presents itself 
during an infant’s first week of life. There are 20–40 cases in Finland each year. 
The bacteria are passed to the child from an asymptomatic mother during 
childbirth and may lead to the death of the newborn or result in a severe 
disability. The GBS screening is used during the final stages of pregnancy in 
order to identify the one out of five mothers who may be carrying the bac-
teria. The infection can then be prevented by effectively treating the mother 
during delivery. 
Debate on this screening procedure began when, in 2005, an abnormally 
high number of newborns (57) in Finland were diagnosed with the infection. 
Screening also included a new method, where the GBS test is performed 
at the commencement of labour. However, it is difficult to ensure that the 
treatment is administered to the disease carrier in time. The test is also 
relatively expensive and providing screening during labour would have 
required the testing of all mothers. In the Finohta report, this was compared 
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to a situation where screening programmes were not conducted as well as to 
the identification of risky labour and late pregnancy GBS screening.
Screening done in late pregnancy produced the best results, with screening 
during labour having nearly as positive an impact, although with significantly 
greater cost. Both screening methods would have increased the use of 
antibiotics considerably. The annual costs of these screening methods were 
estimated at EUR 1.6–3 million, with the cost for one prevented infection 
being EUR 27,000–52,000. Lifelong treatment costs for a possible disability 
were not taken into consideration, nor were training costs included in the 
procedure of launching the screening programme.
The working group on screening did not ultimately take a stand on the 
initiation of a nationwide screening programme. Such a significant increase 
in the number of infection cases as the one that originally sparked the debate 
was not reported again in subsequent years. As with early pregnancy infection 
screening, the State was unwilling to provide funding for the screening 
programme. Both decisions were influenced by the fact that the steering of 
infection screening programmes was also in part vested to the Advisory Board 
on Communicable Diseases of the Ministry of Social Affairs and Health.  The 
impact of screening for infections can be observed in the infectious disease 
registry and individual surveys. 
4.3  screening for MetaBolic diseases  
in newBorns 
Although congenital metabolic diseases are rare, they can lead to serious disa-
bilities or death if left untreated. Finland was the first country in the world 
to begin screening umbilical blood for hypothyreosis (hypothyroidism) at the 
beginning of the 1980s. Umbilical blood screening makes it possible to begin 
treatment before the child is discharged from the hospital. The debate on 
expanding the screening programme for metabolic diseases in newborns was 
started in the early 2000s, on the initiative of experts in the field. Screening 
for phenylketonuria (PKU) in newborns with both or one parent of non-
Finnish descent was implemented at varying rates in different parts of the 
country. 
Umbilical blood samples taken in order to screen for hypothyreosis cannot 
be used in the screening for other metabolic diseases. These diseases can be 
reliably screened for in children no younger than two days, when their own 
metabolism has begun functioning. This ‘blood spot’ screening can be used 
to identify several dozen metabolic diseases. Most of these are extremely rare 
and not all can be treated. In Finland, an assessment conducted in 2005 was 
made of the impact that screening programmes had on five diseases possible 
to detect by screening newborns just a few days old. The early treatment of 
these could prevent a severe disability or death. These five diseases were:
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 Congenital adrenal hyperplasia (CAH)
  Medium chain acyl-CoA dehydrogenase deficiency (MCAD) and 
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD)
 Glutaric aciduria type I (GA I)
 Phenylketonuria (PKU)
The Finohta report estimated that screening for these diseases in Finland 
would make it possible to promptly treat 5–10 children each year, as well 
as to prevent 1–5 cases of severe disability and 1–3 deaths. The direct cost 
of screening was estimated at EUR 45 per newborn, i.e. EUR 2.5 million a 
year. Because PKU is extremely rare among Finns, but far more common in 
other populations, the working group on screening also requested a separate 
assessment of PKU screening programmes conducted on newborns whose 
parents were not of Finnish descent.
The Ministry of Social Affairs and Health working group on screening 
examined the assessment results in several meetings and heard the opinions of 
experts on newborn metabolic diseases. It took years for the working group on 
screening to render a decision, during which time the targeted PKU screening 
was gradually expanded as deliveries were concentrated among increasingly 
fewer units. Finally, the working group on screening proposed offering a 
screening procedure for all five diseases addressed in the Finohta report, to be 
applied to all newborns born in and after 2015. Together with the Association 
of Finnish Local and Regional Authorities, the Ministry of Social Affairs and 
Health sent out a letter concerning the matter to hospital districts in April 
of 2014. In the letter, it was proposed that university hospitals would be 
jointly responsible for planning and steering the screening programme at 
the national level. The public should be provided with information on the 
screening programme; furthermore, sufficient disease diagnostics, treatment 
and genetic counselling expertise should be ensured in all university hospitals. 
No specific guidelines have been drafted for assessing the impact of the 
screening programme, nor were there any guidelines concerning the way in 
which new diseases might be added to the screening programme.  
According to legislative reforms, the responsibility for providing screening 
programmes should be localised in social welfare and health care regions. This 
does not, however, exclude the need for national-level steering of screening 
programmes. The high-quality screening programmes for metabolic diseases 
in newborns requires the involvement of laboratory professionals seven days a 
week, as well as a rapid flow of information between the screening laboratory 
and the hospitals responsible for the treatment of newborns. This is why 
there is a need to centralise laboratory functions, so as to make screening 
programmes cost-effective. In addition, monitoring effectiveness of the 
screening programme requires comprehensive collection of national data.
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4.4 newBorn Hearing screening 
Early diagnosis of hearing impairment in children makes it possible to start re-
habilitation and, if necessary, start using a cochlear implant during the infant’s 
first year of life. The implant aids in the child’s speech development. The be-
ginning of the 2000s saw the introduction of new methods of newborn hea-
ring screening, thus replacing the conventional horn and ratchet. Maternity 
hospitals requested that Finohta investigate new screening methods based on 
otoacoustic emissions (OAE) and auditory brainstem response (ABR).
A rapid review revealed that OAE was better in terms of sensitivity, but 
that ABR provided fewer false positives indicating hearing impairment. Each 
year in Finland, some 670 children under one year of age are given tertiary 
care examinations with the objective of initiating treatment for moderate 
to severe hearing impairment in both ears. In cases where the objective was 
also to detect unilateral hearing impairment, as many as 2,200 children were 
given tertiary care examinations. There were significant differences between 
the methods.
The new screening methods for hearing were assessed at a point when 
only less than half of the maternity hospitals in Finland had adopted one of 
the methods. Although Finohta assessment data was indeed used by many 
hospitals in choosing their preferred method, a key role in decision-making 
was also played by the experiences of other hospitals. A rapid review of the 
subject at the right time influenced the decision to change hearing screening 
methods without regulatory steering. Making a change was perhaps also easy 
because the new OAE and ABR methods were relatively inexpensive and 
their use did not require any changes to the organisation of screening.
4.5 aBdoMinal aortic aneUrysM
An abdominal aortic aneurysm (AAA) usually causes no symptoms until it 
ruptures. Half of all patients with a ruptured aneurysm will die before reach-
ing the hospital, and roughly half of those who do make it to surgery will 
not survive either. An ultrasound examination can reveal an aneurysm while 
it is asymptomatic and it can be treated as prescribed. In Finland, the cost-
effectiveness of this screening was compared to the present practice wherein 
systematic screening is not offered.
The one-off screening for AAA in Finnish men who are 65 years of 
age could prevent approximately 237 deaths in a single age group, and the 
screening of both men and women could prevent 318 deaths. An average of 
10 extra days of life can be achieved for each man screened, with additional 
costs amounting to approximately EUR 170. This amounts to approximately 
EUR 6,000 per additional year of life. Cost-effectiveness can be considered 
reasonable compared to many procedures otherwise performed in health 
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care. As AAA is less common among women, any screening of women would 
produce fewer additional years of life and require less additional costs per 
person than would screening men. The implementation of screening would 
require additional resources for ultrasound examinations and non-emergency 
surgery. 
The Ministry of Social Affairs and Health working group on screening 
has not yet recommended a screening programme for an abdominal aortic 
aneurysm. This type of screening would need to be organised in an entirely 
different way, whereas the other types of screening programmes described in 
this chapter can be conducted in maternity care and maternity hospitals. The 
small increase in lifetime achieved by being screened for an AAA would only 
be concentrated among the elderly population, although age as such does not 
serve as basis for decision-making in health care. Considering that a major 
risk factor for abdominal aortic aneurysm is smoking, reducing one’s smoking 
habit can prevent the formation of an aneurysm. The cost-effectiveness of 
screening could therefore also be considered in relation to efforts to reduce 
smoking. In assessing the cost-effectiveness of screening programmes which 
involve lifestyle habits, it would be a good idea to more extensively assess the 
cost-effectiveness of preventive measures as an alternative approach. 
4.6 conclUsion
Many screening programmes have been gradually introduced without regula-
tory steering, and screening programmes have often been promoted by pro-
fessionals or organisations interested in the topic. In some cases, assessing the 
need for national guidance started when a screening programme already was 
running often due to issues of equality or quality. Today, screening program-
mes are also subject to comparison: What can be considered sufficiently ef-
fective and reasonable in cost? Changes in the incidence of the diseases being 
screened for have also sparked debate. 
Regardless of the manner of steering screening programmes, decision-
makers must have access to reliable information on the effects, costs and 
harms of screening. Information jointly accepted by the population, decision 
makers and health care personnel then lays the foundation for a real discussion 
on values.
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5 cancer screening
nea Malila, tytti sarkeala, ahti anttila
The effectiveness of certain cancer screening programmes has been shown but still, 
all screening is not necessarily beneficial. The benefits and harms of screening must be 
balanced. when screening is applied as an actual public health programme, the impact 
is smaller than expected based on trials. Screening registries are important, so that 
the screening programmes, participation in them and, above all, their effectiveness can 
be assessed and monitored.
Cancer screening aims to find early-stage pre-clinical (asymptomatic) cancers 
or their precursors, thus making it possible to prevent cancer-related deaths 
(or in some cases, the occurrence of cancer). Screening programmes can also 
offer indirect benefits, such as reducing the need for burdensome adjuvant 
treatments. Where society is concerned, early-stage treatment offers cost sa-
vings, as the treatment period is short and the need for expensive therapies 
is often eliminated. However, screening does have some disadvantages, such 
as anxiety and concern, false screening results (both false positive and false 
negative results) and overdiagnosis of early-stage cancers or precursors. In a 
good screening programme, the advantages and disadvantages are balanced, 
and there is ample research-based information available.
Screening involves a long chain of various health care functions and actors. 
The screening chain is a process that begins with defining the population to 
be screened, delivery of invitations, performing tests and interpreting them, 
and performing any necessary diagnostic and treatment measures. The chain 
ends finally at death of the subject. In a screening programme, it is precisely 
specified in advance when and what will be done depending on a given test 
result. The chain is sensitive to disturbances - failure of the weakest link can 
destroy the entire program. The screening chain should be assessed on a 
regular basis. Assessment allows for the comprehensive national registration 
of information produced in the various stages of screening.
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5.1  screening PrograMMes sPecified  
in tHe screening decree
Under section 14 of the Health Care Act (1326/2010), municipalities are re-
quired to offer screening that comply with the national screening programme. 
The Screening Decree (339/2011) prescribes the national screening program-
mes and the general principles by which they must abide. The Decree also 
prescribes the obligation to provide information: the provider must inform 
participants on the arrangements, objectives, effectiveness and potential risks 
of screening. National cancer screening programmes that are mandatory to 
organize include cervical cancer screening every five years for women 30–
60 years of age and breast cancer screening every 20–26 months for women 
50–69 years of age. The effectiveness of cancer screening programmes is eva-
luated in terms of cancer specific mortality. However, in some cases, various 
intermediate indicators, such as detection rates or stage distribution of cancer, 
are used. Intermediate objectives should not, however, be used in assessing 
the effectiveness of the screening programme and when deciding whether to 
launch new programs or extend current screening programs.
Participating in screening is voluntary. Those invited should be provided 
with sufficient information to support their decision. The information should 
be impartial, accessible and understandable, covering both the advantages 
and disadvantages of screening. The invitation to screening is a good, natural 
channel for providing information, as all those invited to participate in screening 
receive one. Still, it is important to enhance the coverage of the screening 
programme, as low participation rates reduce the impact of screening. As tests 
and imaging performed outside the screening programme are not monitored 
centrally, comprehensive data on their quality or effectiveness is not available.
5.2 cerVical cancer screening
The cervical cancer screening programme was launched in Finland at the be-
ginning of the 1960s, and it was expanded into a national programme by the 
end of the decade. There was  a clear reduction in the incidence and mortality 
of cervical cancer after the implementation of the screening programme (as 
much as a 80% reduction in the whole country). The benefit provided by 
screening cannot, therefore, be questioned. 
The incidence of cervical cancer increased among young women in the 
1990s, which is also why it has been proposed that the onset age for screening 
should be lowered. Research evidence, however, does not support lowering the 
screening age from the current 30 years, because screening of young women 
would increase the disadvantages of screening (self-healing HPV infections 
are diagnosed a great deal, particularly in young women) without improving 
its effectiveness. On the other hand, it might be justifiable to increase the 
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screening up to age 65, because cancer is more common among the elderly, 
and women have long lifespans. 
The effectiveness of screening has also fallen following a drop in 
participation, particularly among women under 40 years of age. There is 
much to be corrected in municipal practices, which can be done through 
simple means, e.g., offering of a pre-reserved appointment with the screening 
invitation and re-inviting those who have not participated. 
HPV testing has been studied as part of the normal screening programme. 
Even though the test can reveal a lot of precursors, its impact on invasive 
cancer during one screening interval is the same as that of a conventional Pap 
test. When girls who have received the HPV vaccination reach screening age – 
after approximately 15 years – the role of the screening test will have to be re-
assessed. At the moment, the HPV test is not recommended at all for women 
under 35 years of age, because HPV infections are common among young 
women and usually clear up on their own. Use of an HPV test can thus result 
in overdiagnosis, due to minor inflammatory precursory changes. Likewise, 
the HPV test should be administered to women 35 years of age and older 
systematically, so that the impacts caused by changes in the test throughout 
the screening process and its results can be confirmed.
5.3 Breast cancer screening
In Finland, breast cancer screening programmes based on mammography are 
provided to women 50–69 years of age every other year. The breast cancer sc-
reening programme was launched in Finland in 1987 with a quasi-randomised 
research framework among women aged 50–59. The programme expanded to 
include women over 60 years of age beginning in 2007, thus the obligation 
to provide screening until 69 years of age applies to women born in 1947 or 
later. In the early years of screening – 1987–1991 – only women born in every 
other birth year were screened, thus leaving the remaining women to serve 
as a control group. The effectiveness of the Finnish breast cancer screening 
programme was assessed after the four year implementation period and again 
later, based on monitoring by the Finnish Cancer Registry. In Finland, breast 
cancer screening has achieved an approximately 20–25% reduction in mor-
tality. We have been able to explain the justification for screening well, and 
the programme has not been compromised even by the heated debate on its 
impacts. 
The adverse effects of screening, such as overdiagnosis of slow-growing 
cancers and localised tumours (in-situ cancers), have sparked debate. An 
international estimate states that the rate of overdiagnosis in screening 
programmes conducted among women aged 50–69 is 11–19%. According to 
a recent assessment published from Finland, the rate of overdiagnosis among 
women aged 50–69 has been 5–7% on average (range: 1–13%). 
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5.4 colorectal cancer screening
Colorectal cancer screening has been proven effective (reducing the mortality 
from colorectal cancer) – when done either by faecal-occult blood screening 
or by using sigmoidoscopy as the primary screening test. Use of the faecal-
occult blood tests in screening is based on the fact that colorectal growths 
bleed more frequently than a healthy mucous membrane. On average, scree-
ning reduces the mortality resulting from colorectal cancer by 16%, although 
recent estimates suggest a lower figure. 
The colorectal cancer screening programme in Finland was launched 
within a research framework, where half of the population are invited for 
screening (screening group) and the other half of the target population serves 
as a control group. The guaiac based faecal-occult blood test is used as the 
primary screening test. The objective was to determine whether trial results 
could be applied to Finnish health care. Randomising was used to ensure a 
fair and balanced screening launch, a reliable and unbiased assessment of the 
screening programme, and the sufficiency of health care resources, such as 
colonoscopies.  
The impact of the colorectal cancer screening programme is currently 
being examined, as the 10-year randomisation period set by the working 
group on screening came to a close at the end of 2014. Even though the 
programme seems to be working well – participation is approximately 70% 
and the provision of diagnostics and treatment has proceeded well – no final 
decision on screening can be made without a longer follow-up to estimate the 
possible mortality reduction. 
5.5 Prostate cancer screening
Cancer of the prostate gland is the most common type of cancer among men, 
both in Finland and in many other countries with a high standard of living. 
An extensive multicentre trial, the European Randomized Study of Screening 
for Prostate Cancer (ERSPC), was launched in the early 1990s, with Finland 
joining in 1996. After over ten years of follow-up, it was found that PSA 
screening reduces the mortality rate of prostate cancer in those invited to 
participate in screening by 21% compared to the control group, and by 29% 
in participants after adjustment for non-compliance. In the Finnish part of 
the trial, the mortality reduction was lower – approximately 15% – and not 
statistically significant. A recent Cochrane review states that the impact of 
screening on mortality was not irrefutably proven in the meta-analysis of five 
randomised controlled trials. This result is due to the fact that the American 
Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial and 
ERSPC produced conflicting results.
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An organised prostate cancer screening programme in Finland has not yet 
been launched, also because prostate cancer treatment has significant adverse 
impacts on the quality of life. Active treatment involves long-term factors that 
deteriorate the quality of life, such as urinary incontinence, burning sensation, 
erectile dysfunction and, particularly in radiation therapy, intestinal irritation. 
Despite this, PSA tests have largely been conducted, e.g. in occupational 
health care, the private sector and also in public health care. The situation 
is a paradox, because ‘opportunistic screening’ emphasises the disadvantages 
and reduces the number of advantages of screening: the interpretation of 
screening results varies, and the screening threshold value differs between 
units; follow-up/diagnostic examinations are not provided on a systematic 
basis; the access of subjects to examinations and treatment is not monitored 
systematically; and data is not compiled for assessment. 
Screening-type PSA-testing to find prostate cancer should not be 
continued in the present scope, but the testing of healthy men for the sake 
of certainty should rather be discontinued. Alternatively, there should be a 
national programme which would ensure adequate availability of information 
on the advantages and disadvantages of screening to help subjects make an 
informed decision.
5.6 lUng cancer screening
Lung cancer screening using conventional x-ray imaging is ineffective, i.e. it 
does not reduce mortality from lung cancer. Conversely, screening with a low-
dose computed tomography (CT) scan reduced lung cancer mortality by 20% 
and overall mortality by 6.7% compared to using a conventional lung x-ray, 
according to the findings of an American screening trial. The target populati-
on of the trial were long-term smokers, with screening conducted once a year 
over a period of three years. As shown by the trial results, screening seems 
to reduce lung cancer mortality in a high-risk population. The challenges of 
lung cancer screening include issues of how it should be organised, what the 
disadvantages are with numerous additional examinations and how a suitable 
high-risk target population can be identified and invited for screening. 
Because smoking is a well-known and extremely high risk factor for lung 
cancer, cutting down on smoking remains the primary health policy tool for 
prevention of lung cancer. 
5.7 otHer cancer screening PrograMMes
Screening for oral cancer by means of visual inspection has been proven to 
reduce mortality of high-risk persons (smokers, heavy drinkers). Screening for 
ovarian cancer, on the other hand, has not been shown to reduce mortality. 
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In Australia, there is a total-body melanoma screening trial underway. The 
first results of the trial are expected to be ready in 2015. Although efforts 
are being made to widely reduce the risk of skin cancer, particularly melano-
mas, by means of mole monitoring, there is no research data on its efficacy. 
Screening for gastric cancer was tested in Finland among men in the cities 
of Vantaa and Kotka in 1994–95. The trial results of gastric cancer mortality 
have not yet been published and, at present, gastric cancer screening does not 
seem to be suitable to be made into a population based screening programme. 
5.8 sUMMary
Because population screening programmes are focused on healthy individu-
als, the advantages and disadvantages must be balanced before initiating any 
screening programme. Minimising the disadvantages is particularly important. 
A functional screening programme also includes the proper guidelines for 
the screening interval and target age. The screening interval should be suffi-
ciently long, so that the adverse impacts of screening can be minimised, but 
also frequent enough to ensure that early-stage cancers and precursor lesions 
are found in time. The benefits of cancer screening programmes appear at 
the population level as a reduction in the mortality resulting from cancer. A 
good screening indicator is also an improvement in the patients’ quality of life 
which comes with less invasive, therapeutic treatments. A functional scree-
ning programme is a finely-tuned chain of activities, in which any necessary 
follow-up examinations are agreed upon in advance. The strength, but also 
a challenge, of screening programmes is the process as a whole – a screening 
chain which needs constant monitoring and care. 
45
6 HealtH exaMinations
riitta sauni, tuovi Hakulinen-Viitanen, Marjaana 
Pelkonen, Marjukka Mäkelä, erkki Vartiainen, 
timo leino taneli Puumalainen
Although health examinations may include elements of screening, their objective is 
not only to find diseases or their precursors, but also to promote health, well-being 
and work ability. Health examinations for children and young people place an emphasis 
on monitoring and supporting growth and development. For adults, the emphasis is 
given to promoting health and functional capacity as well as supporting work ability.
There are many points in common between screening programmes and health 
examinations. According to the definition found in the Screening Decree, sc-
reening entails an examination or sampling of the population, or a certain 
part of the population, in order to discover a certain disease or its precursor, 
or in order to identify a pathogen. Health examination is a broader concept. 
According to the definition provided by the Ministry of Social Affairs and 
Health, health examinations are used to assess an individual’s health conditi-
on and functional capacity by means of clinical examinations or other suitable 
and reliable methods. At the individual level, it is defined as a multifaceted 
examination of the individual’s health condition and it may include elements 
of screening. Health examination is the general term used to describe a mee-
ting between a health care professional and an individual coming in for an 
examination. It serves as a platform which can involve various examinati-
on, advisory or guidance elements, depending on the situation. The elements, 
such as the content of maternity or child health clinic examinations, are gene-
rally agreed upon in advance, but they are adapted and weighted in different 
ways in accordance with individual needs.
The purpose of health advice and health examinations is to monitor and 
promote public health and well-being, to promote working and functional 
capacity, prevent diseases, promote mental health and life skills, support 
choices that promote health and prevent diseases, offer nutritional and 
fitness advice, and support efforts to quit smoking and cut down on alcohol 
consumption in order to prevent chronic diseases.
The aim of health examinations is the primary and secondary prevention 
of diseases. Screening tests can be used as a tool in finding changes that require 
either tertiary care examinations and monitoring or treatment. Appendix 
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1 lists various types of health examinations and the associated screening 
examinations.
Health-promoting health examinations include those conducted in 
maternity clinics, child health clinics, those pertaining to school and student 
health care, and those provided by many occupational health care services. 
There are also several health examinations which an individual is required 
to pass in order to obtain certain permits or positions (e.g., driving licence, 
diving, pilot licence or military examinations as well as some occupational 
health care examinations). In such cases, the applicant must possess certain 
types of physical attributes in order to ensure their own safety and that of 
others. . Figure 2 shows the various general screening programmes and health 
examinations aimed at the public, divided by five-year age groups.
Screenings and health examinations in Finland 2014 
L = Child health clinic 
14 L K = school and student health care 
13 L P = Defence Forces 
12 L A = Driving licence 
11 L Ä = Maternity clinic 
10 L T = Occupational health care 
9 L C = Cervical cancer (women) 
8 L R = Breast cancer (women) 
7 L 
6 L R 
5 L K K R R 
4 L K K A C R R R 
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2 L K K K T T T T T T T T R R 
1 L L K K T T T T T T T T T A A A A A 
 0- 6- 11- 16- 21- 26- 31- 36- 41- 46- 51- 56- 61- 66- 71- 76- 81- 86- 
 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90  
Figure 2. Screening programmes and health examinations aimed at the public, 
divided by five-year age groups. Screening programmes only intended for 
women are shown in the white field. Multiple visits are made to the maternity 
clinic (not specified). According to the total fertility rate (1.8), an average of 
two pregnancies per woman is included. 80% of the population holds a driving 
licence.
A health examination is based on the division of duties agreed upon 
between the health care nurse and physician. From a performance standpoint, 
it is essential that enough time be set aside for the health examination, as well 
as that the staff is highly skilled and can consult other professional groups. 
The opportunity for referral to tertiary care examinations and treatment, as 
well as having functional, multidisciplinary teams, is also essential. 
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6.1  wHy are HealtH exaMinations for 
cHildren, yoUng PeoPle and faMilies 
condUcted?
Health examinations are conducted in order to proactively enhance factors 
that protect the health and well-being of children and young people. There 
are strong research-based justifications for health examinations’ protective 
factors and their enhancement, with new data being produced constantly.
Furthermore, health examinations are conducted in order to detect 
problems or risk factors (developments, conditions, symptoms, diseases and 
abnormalities) that threaten the growth, development, health and well-being 
of children and young people as early as possible. This also involves providing 
advice, guidance and support, and taking the necessary measures. The above-
mentioned problems may have to do with the children or young people 
themselves (psychosocial development and health; neurological development, 
interaction, speech and language; physical health, growth and development, 
incl. health habits, puberty; safety; vision and hearing; oral health), or with 
their growth and development environments (e.g. parents, home), which 
are dependent factors in a child’s or young person’s development and well-
being.  The measures to be taken might be, for example, support or guidance 
provided immediately during an examination, agreeing on a more in-depth 
examination of the situation, planning support measures, and referral to 
tertiary care examinations or treatment. If the problems are complex, it will 
be necessary to ask for the input of other professional groups, often involving 
multidisciplinary co-operation. If necessary, a personal well-being and health 
plan is made.
A good health examination always includes a portion that focuses on 
enhancing health, well-being and capabilities; problems should never be the 
only focus. Health examinations for children and young people are based on 
a positive perception of health, and on an approach which aims to enhance 
the examinee’s capabilities.
The environment in which children and young people a growing and 
developing (home, day care, school/educational institution, free time) is 
taken into consideration in every health examination. Guidelines on health 
checks and scheduling related examinations can be found in various guides 
and manuals (Ministry of Social Affairs and Health Handbook 14/2004, 
Ministry of Social Affairs and Health Publication 20/2009, National Institute 
for Health and Welfare Guidebook 22/2012). These list the justifications for 
health examination subsets, and stipulate the examinations to be conducted 
on different age groups, including examples of diseases, disabilities and 
problems which are key targets for the examinations in question. Extensive 
health examinations, in which the health and well-being of the entire family 
is assessed, are more comprehensive than other types of examinations, and 
require a longer appointment time. Other health examinations conducted 
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between extensive ones can be more limited in scope and shorter in duration, 
as needed.
Surveys, studies, forms, interviews, etc. are used in identifying problems 
and need for support. Examples of methods used in maternity clinics and 
school health care are presented in the National Institute for Welfare and 
Health method manual (Handbook 14/2011) and in the appendix to the 
working group report on the development of student health care (MSAH 
10/2014). Current Care Guidelines and nursing recommendations are also 
used. Assessments made by other professionals, such as day-care and school 
staff, are also used to increase the reliability of assessments and effectiveness 
of tertiary care measures. 
In order to improve the quality of preventive services for children and 
young people, and minimise the degree of variation between municipalities, 
certain child health clinic and school/student health care examinations, as 
well as their attendant health advice, have been made statutory (Government 
Decree 338/2011). Health examinations are conducted most frequently 
during pregnancy and nursing, because growth and development are intensive 
at this stage, and any delay in identifying potential problems can have serious 
consequences. Many parents also need a great deal of guidance and support 
at this stage. At a later growth age, too, changes come quickly, so regular 
health examinations are vital to monitoring, for example, growth, puberty 
and posture. In recent decades, the number of health examinations has been 
reduced in, for example, child health clinics and, more recently, in maternity 
clinics. More time is now spent on targeting services (National Institute for 
Welfare and Health Handbook 29/2014). It is for the above-mentioned 
reasons that an annual school health care appointment is justified. While 
in secondary level education (upper secondary school/vocational school), 
young people are at an age where risk behaviour is common and independent 
health habits are being formed. In addition, many mental disorders begin 
at this stage of life. Providing support for the well-being of young people 
and identifying problems early is possible in health examinations conducted 
in the first and second year of secondary education. In student health care, 
health examinations are conducted on the basis of the results of a health 
survey. Student health care includes the early diagnosis, treatment and follow-
up treatment of mental health and substance abuse problems.
Under the above-mentioned Decree, municipalities were made 
responsible for identifying children, young people and families in need of 
special support, and for determining the support needs of those failing to 
attend health examinations. The purpose is to identify need for support early, 
and to allocate support at the right time for those who need it, so as to reduce 
health disparities and prevent marginalisation and the need for child welfare. 
The services for children, young people and families are universal, intended 
for the entire age group. This is due to the fact that it is impossible to know 
in advance who will need support. Other national guidelines, monitoring and 
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supervision were enhanced in connection with strengthening of the legislation 
(Health Care Act/Decree). The provision of high-quality health examinations 
is also related to how motivated municipalities are to invest in the well-being 
of children and families (capabilities, management, expertise).
6.2  wHy are occUPational HealtH care 
exaMinations condUcted?
Health examinations are a part of occupational health care, serving a preven-
tive purpose and promoting occupational health. Their objective is to protect 
employees from work-related health risks as well as to promote the emp-
loyees’ own capabilities and health in order to maintain their work ability. 
Effort is made to take preventive, corrective and rehabilitative measures for 
individuals and the workplace as early as possible. 
An assessment of the need for a health examination is made by 
occupational health care professionals in co-operation with the workplace. 
If necessary, occupational health care experts are also used. According to 
Government Decree 708/2013, issued under the Occupational Health Care 
Act (1383/2001), occupational health care examinations shall be conducted;
  “...when so required by the age, sex or physiological state of the 
employee and by work-related health risks and problems;
  when abnormal work shifts or night work so require;
  when the health effects of new technologies, methods and substances 
being introduced so require;
  where necessary to establish the state of the employee’s health and 
any necessary follow-up also after the end of exposure;
  on the basis of special health requirements of the work;
  as necessary when a material change occurs in the work or at different 
stages of the working career;
  when the employee’s health and work ability at different stages of an illness 
so require;
  where necessary to assess and support the possibilities for coping on 
the job and, as necessary, to adapt the work to suit the employee’s 
capabilities, health requirements and working and functional capacity.
  where necessary to assess the health and work ability prior to the 
termination of employment and determine the health requirements 
for employment as well as to draft a plan for the maintenance of 
health and work ability and referral for follow-up procedures.”
During a health examination, attention is paid to the employee’s health 
condition, work ability and functional capacity as a whole and, in particular, 
to the correlation between work and health. The health examination provides 
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a basis for assessing the need for advice and guidance, and a personal health 
plan is prepared in co-operation with the employee in order to promote their 
work ability.
6.3   different tyPes of occUPational  
HealtH care exaMinations
Occupational health care examinations can be divided into pre-employment 
examinations and regularly scheduled examinations. In practice, nearly every 
new employee is given a health examination at the beginning of employment, 
even though these preliminary examinations are only compulsory if the work 
involves health risks that may lead to illness or overexposure, or pose a threat 
to reproductive health. 
Under currently applicable legislation, regularly scheduled examinations 
must be conducted “...when an employee is performing work that presents a 
special risk of illness or accident” (Government Decree 1485/2001). Today, a 
major part of Finnish occupational safety and health legislation is drafted in 
EU organs, at the initiative of the European Commission. One point included 
in many EU directives on occupational safety and health is the obligation 
to provide health examinations to employees exposed to occupational 
hazards (e.g. asbestos, noise, vibration, night work, electromagnetic fields). 
The objective of these health examinations is to ensure that occupational 
exposure does not pose a health hazard. 
According to Social Insurance Institution of Finland (Kela) statistics, a 
total of approximately one million occupational health examinations have, 
for a long time already, been conducted on a yearly basis. This means that 
50–60 health examinations have been conducted for every 100 employed 
persons. In 2011, more than 17% of health examinations were conducted 
for cases involving serious risk of illness and the remainder were health and 
work ability-based examinations. It has been possible to target health and 
work ability-based examinations according to a specific age group or unit; 
for example, every 3–5 years. As municipalities have relinquished a large 
percentage of adult age-group examinations, it can be said that occupational 
health care has also assumed responsibility for providing public health care 
in this respect.
Health examinations which screen persons for potential work ability 
risks have become more common in recent years. There is scientific evidence 
to support the efficacy of this practice. Risk factors related to health and 
work ability are identified by providing employees with online or paper form 
surveys. Applicants whose surveys indicate health risks that may pose a threat 
to work ability are then invited for a personal health examination and are 
provided with support. With regard to screening examinations, it has to be 
ensured that the entire target group will still be able to participate in health 
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examinations if so desired, because it is possible that the screening survey 
does not reach everyone in need of assistance. It must also be ensured that 
the surveys are valid, and that it is known who is being reached by the survey 
and who is not.
A multi-professional approach in occupational health care involves 
teamwork based on the multidisciplinarity which underlies various professions. 
The occupational health team consists of an occupational health physician, 
nurse, psychologist and occupational physical therapist, but it can also include 
other occupational health care experts, if so required by the workplace or 
employee. Occupational health nurses conduct most of the examinations 
(58%), while physicians account for 28%, physical therapists for 10% and 
psychologists for 4% of the conducted examinations. The occupational health 
nurse is usually the one who then directs the client to a physician or other 
occupational health care expert. In health examinations of cases involving 
serious risk of work-related illness, the physician’s opinion is absolutely 
necessary.
6.4   content of occUPational  
HealtH exaMinations
In work involving serious risk of illness or accident, an examination’s content 
can be very specific; e.g., a hearing test or biological exposure test, in which 
blood and urine samples are screened for occupational exposure to certain 
chemicals. These examinations are compulsory for employees. The scope and 
content of the examinations aimed at determining health, working and func-
tional capacity is determined through a needs assessment, which is conducted 
in co-operation with the workplace and the set targets. Conducting examina-
tions requires the consent of the employee. 
An occupational health examination incorporates clinical examinations 
and other suitable and reliable methods. If the occupational health 
examination includes screening, it is important to define the health targets 
of the screening procedure, to determine how possible it is to achieve 
these targets through screening, and to determine what the best screening 
methods are. the regulations found in the Government Decree on Screenings 
(339/2011) regarding screening procedures compliant with the national 
screening programme must also be taken into account. No screening-type 
examinations that fail to meet these screening criteria should be included in 
a health examination.
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6.5  HealtH exaMinations for iMMigrants
Finland does not impose health requirements on immigration, nor does its 
immigration policy contain any health-related statements or take positions on 
the matter. Immigrants are not turned away at the border for health-related 
reasons, and officials who process residence permit applications are not allo-
wed to know the results of screening tests taken during or after the entry exa-
mination. The Ministry of Social Affairs and Health recommends providing 
health examinations for refugees, asylum-seekers and for members of their 
family who arrive in Finland later, as well as for persons arriving from count-
ries with a high incidence of tuberculosis  and are planning to stay in Finland 
for a period longer than three months. In addition to this, some municipalities 
provide other immigrant groups with health examinations as part of the in-
tegration process. Participation in health examinations is voluntary.
Refugees and asylum-seekers, and the problems of preventing infections 
among them, is presented in the Ministry of Social Affairs and Health 
guideline 2009:21, which specifies the arrangement procedure, cost liabilities 
and medical contents of health examinations aimed at these groups. An 
examination in this case involves a visit to a clinic nurse or, if necessary, to a 
physician; a lung x-ray taken to screen for tuberculosis; and laboratory tests 
to screen for HIV, hepatitis B and syphilis. Children are also screened for 
intestinal parasites. The person’s vaccination history is also examined during 
the clinic visit.
In 2014, the Ministry of Social Affairs and Health also issued guidelines 
regarding the early diagnosis of pulmonary tuberculosis during immigrant 
health examinations. If it is likely that their stay in Finland will be longer 
than three months, immigrants from countries with a high incidence of 
tuberculosis (List of countries to be found at: http://www.thl.fi/attachments/
Infektiotaudit/Maaluettelo.pdf) must be offered a voluntary screening for 
tuberculosis,. This screening procedure involves a preliminary interview with 
a nurse or public health nurse within two weeks of arrival in Finland and, 
during the same clinic visit or as soon as possible after it, a lung x-ray. The 
objective of the screening is to protect the immigrant’s own health and break 
the chain of infection, thus also protecting the general public from developing 
tuberculosis infections. 
6.6 HealtH exaMinations for tHe UneMPloyed
As stated in section 13 of the Health Care Act, which entered into force in 
2011, “[m]unicipal health counselling and health checks shall also be made 
available to young people and individuals of working age who are not covered 
by student health care or occupational health care.” Based on a national health 
centre survey conducted in 2013, the municipalities had been responsible for 
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providing more health examinations for the unemployed, and related servi-
ces, than they were in 2009. Of the municipalities responding to the survey, 
approximately half had provided health examinations for the unemployed in 
2009, whereas the figure in 2013 rose to 89%. Although health examinations 
are conducted quite comprehensively throughout the country, there is no 
precise data on the number of clients. Nearly all the municipalities currently 
providing health examinations had agreed to continue doing so. Two factors 
contributing to this continuity are needs-based activities and prescribed co-
operative practices.
6.7 otHer HealtH exaMinations
In order to obtain certain official permits and licences, it is required to under-
go a medical examination, which also includes a health examination. This is 
necessary for, e.g., driver’s licences, pilot’s licences or a certificate of compe-
tency for a person who sets off explosives. It should also be assessed whether 
it is safe for a person to scuba dive before they participate in any such training 
programme. In the Finnish Defence Forces, health examinations are conducted 
whether a person is fit for military service – this is done during the call-up, 
when arriving for service, and at the end of service. Some municipalities pro-
vide health examinations for the elderly, which focus on assessing functional 
capacity and factors related to living at home. Oral health examinations are 
conducted in order to assess oral health, development and possible need for 
treatment. If necessary, a personal health plan is made. The municipality must 
provide these examinations to all persons belonging to a predetermined age, 
class year or other group, as well as based on individual need.
6.8  screening for cHronic diseases  
in HealtH exaMinations
Risk assessment of cardiovascular diseases
Each adult should be aware of their blood pressure and cholesterol level. 
According to USA recommendations, the overall risk should be assessed once 
every 4–6 years after the age of 20 in low-risk cases and more frequently 
in higher-risk cases. According to European recommendations, it would be 
good to assess the risk among all adults, but at least among men 40 years 
of age and women 50 years of age. The easiest way to measure overall risk 
is with the FINRISKI calculator, (http://www.thl.fi/finriski-laskuri) in which 
users enter their age, gender, total cholesterol, HDL cholesterol, systolic blood 
pressure, smoking habits, diabetes (if any) and whether their parents had a 
heart attack or stroke at a young age. The calculator expresses the probability 
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of contracting a cardiovascular disease, dying of atherosclerosis or a stroke, as 
well as the combined risk of all the aforementioned factors. The calculator 
also provides the risk for a man or woman of a certain age, belonging to a 
low-risk group, to contract a cardiovascular disease; the calculator also shows 
the median risk for a Finnish man or woman of a certain n age possessing 
typical risk factors. FINRISKI is most useful for middle-aged members of the 
population, as the absolute risk for young adults is overall very low. However, 
the relative risk for a young adult can be determined by comparing their risk 
factors to others in the same age group, or by determining what their risk 
would be at the age of 60 given the continuation of the same lifestyle. Also, 
the predictive value of risk factors for cardiovascular diseases in older people 
declines. Further treatment should be planned and carried out in accordance 
with the Current Care Guidelines for dyslipidemia and high blood pressure 
(Dyslipidemia, High blood pressure). 
Risk assessment for diabetes
The risk of diabetes is easy to assess with an online test, which requires no 
laboratory testing: http://www.diabetes.fi/files/502/eRiskitestilomake.pdf.
The test can also be taken in paper form. The two-hour glucose tolerance test 
should be taken at the 12-point risk limit or 15-point risk limit, depending on 
availability. Treatment should be given in accordance with the Current Care 
Guidelines for diabetes (Diabetes). 
6.9  tHoUgHts on tHe Benefits and 
effectiVeness of HealtH exaMinations
There are numerous benefits offered by health examinations. Some of these 
benefits can be precisely measured (diseases prevented by vaccination or other 
means, detected hearing impairment, etc.). Others are experiential, such as 
the experience of a father or mother receiving assistance and strengthening 
their capabilities in child-rearing. The effectiveness of a health examination 
therefore consists of several factors, some of which reveal their impact 
immediately and others only after several years. One example of delayed 
impact includes the early detection of learning disabilities, with treatment 
benefits seen through improved learning skills at the comprehensive school 
level. Furthermore, the early identification of behavioural problems has a 
major impact on the children themselves, their parents and society as a whole. 
Appendix Table 2 shows research data on the benefits of operating models 
or work methods used in health examinations at maternity and child health 
clinics, and in school health care.  According to the data, there are substantial 
potential health benefits of the operating models and work methods, influencing 
children, young people and parents. The benefits of health examinations and 
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the accompanying advice depend on in the circumstances of the examinations: 
How are the children and parents treated? How effectively can one support 
the well-being of parents, children and young people and make changes for 
the better? How effectively can problems or need for support be identified, 
and tertiary care measures taken?
Health examinations produce more benefits when the actors support 
protective measures more effectively, and address concerns and problems 
early and effectively. It is cost-effective to provide assistance to a child and its 
family as early as possible, before the problems have established themselves. 
If problems are addressed only after years of waiting, the situation is usually 
exacerbated, assistance is more difficult to provide, and costs multiply.
Health examination procedures should be presented in a sufficiently 
effective way. A single recommendation to stop smoking or to lose weight is 
most effective when a person frequents the same health care professional, who 
prescribes recommendations so as to suit the life situation of their patient. 
Motivational interviews have produced good results in changing health habits.
Health examinations form a continuum, which is used to regularly 
monitor and improve the health and well-being of every child, young person 
and family, and in which interventions are made when necessary. Assessing 
the effectiveness of only a single health examination is rarely possible 
or desirable. A health examination is a multi-dimensional whole, whose 
value and accompanying benefits depend on a variety of factors, such as 
management and employee skills, as well as the functionality of the service 
entity. It is important to treat a child and its parents as unique individuals, 
create a confidential relationship and develop the ability to take the needs 
of individuals and the population into consideration, thus facilitating 
participation (see also Government Decree 338/2011).
Health examinations for children and young people include various 
measurements, which can be used to monitor their growth and development. 
Other health examinations use ther types of. Measurements can be studied 
based on how effectively they identify anomalous results. However, 
conducting randomised studies on health examinations as a whole is not 
possible. The measurements in question, and the actions taken based on them, 
can nevertheless be used to assess both positive and negative impacts. 
For adults, health examinations usually observe either work-related 
health risks, risk factors for chronic diseases or, more broadly, health and 
functional capacity surveys. With regard to cardiovascular disease risk 
factors, blood pressure and cholesterol, health examinations primarily entail 
risk management. The risk of contracting a cardiovascular disease increases 
linearly as blood pressure or cholesterol level rises. Consequently, it is a good 
idea to make changes in one’s health habits regardless of risk levels; however, 
medicinal intervention is recommended at certain (high) risk levels. Following 
a health examination, changes to one’s health habits require the development 
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of a systematic programme, while a medicinal intervention requires a patient 
to be monitored and motivated. 
6.10 recoMMendations for deVeloPMent
Throughout one’s life, health examinations are conducted due to a variety of 
needs and requirements placed by, for example, maternity clinics, school and 
student health care, the military, occupational health care and immigration 
authorities. The examination results are recorded in information systems, 
using free-form text and structure. Some data, such as vaccination history, 
functional capacity limitations or a personal health plan, should be attributed 
to person throughout their lifetime. This, however, does not happen in reality, 
because each health service provider keeps their own records, which are not 
transferred along with the person to a different service provider. There is an 
obvious need for cross-organisational transfer of information.
A silo mentality (when several departments or groups do not want to share 
information or knowledge with other individuals in the same organisation) in 
health care, and interruptions in the flow of information, cause a great deal 
of unnecessary work and compromise the ability to monitor a person’s health 
and working and functional capacity effectively over the long term. The 
National Archive for Health Information (KanTa) Patient Data Repository is 
intended to solve the aforementioned problem. Health care providers enter 
patient data into the system, and the system retrieves key patient treatment 
data from archived records for the same or other health care providers, and 
for the citizens themselves to see. The structure and content of the Patient 
Data Repository should be developed so as to it easy to find not only key 
health information, but also information on conducted health examinations 
and personal health plan.
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7 closing reMarKs 
liisa-Maria Voipio-Pulkki
The starting point of Screening in Finland 2014 was the unanimous view of the 
working group on screening that national steering of screening programmes 
should be strengthened. For this purpose, it was necessary to present a compact 
review of the history, present state and current issues of screening in Finland. 
The structural reform of social welfare and health care currently underway 
will change the responsibilities for providing screening services. Responsibility 
for screening processes will be collected to a few social welfare and health 
care regions. The reform lays a strong foundation for a uniform, seamless, 
effective and cost-effective provision of screening programmes in Finland also 
in the future. 
New screening programmes and screening-type functions are constantly 
becoming available. There are also changes in the core screening activities 
of the national screening programme – there is constant change in screening 
methods, population structure, epidemiology, and treatment methods of 
diseases being screened for. This is why the national screening programme 
should be critically assessed at least every decade. On the other hand, building 
a well-functioning screening chain takes years, as can be seen from the 
description of launching the prenatal screening programme in this book. 
Screening programmes that have been proven effective in a carefully 
constructed study design might not necessarily be applicable as such, 
or implementable in Finnish conditions. The examples described in this 
publication – screening for neonatal metabolic diseases and abdominal 
aortic aneurysms – illustrate the difficult points which the working group 
on screening needs to consider when discussing a possible widening of 
the national screening programme. The challenging 0economic situation 
of municipalities and the current inability of the statistical authority to 
monitor the implementation and effectiveness of new mandatory screening 
programmes all have an impact on the chosen course of action. The social 
welfare and health care reform, and the reform of the personal data register 
legislation, which are currently being prepared, will aid decision-making 
on the national screening programme. Quality control of all screening and 
monitoring implementation should be co-ordinated by a single authority, in 
co-operation with the new social welfare and health care regions. 
The criteria which a screening procedure needs to fulfil are demanding, 
and the threshold for gaining approval as a mandatory national screening 
programme is therefore high. However, there are many useful health care 
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activities, usually as part of health examinations, which resemble screening 
but do not necessarily meet all the classic criteria for screening. This is why 
this publication includes a description of health examinations intended for 
different age groups. It is important that health examinations are planned and 
implemented in a way that does not reduce public participation in the actual 
screening programmes. 
People’s interest in promoting their own health, as well as in health 
information in general, is rapidly proliferating and changing. For example, the 
first strategy for the use of national genomic data is currently being prepared. 
Combining national databases, health information produced by people 
themselves, and open data, can create entirely new opportunities for targeting 
appropriate measures and for promoting public health. In the future, the 
national screening programme is going to be evaluated in light of these new 
opportunities. The working group on screening hopes that this publication 
will spark debate on the future of the national screening programme, and 
that all people entitled to Finnish social welfare and health care services will 
continue to have access to uniform and effective screening programmes. 
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goVernMent decree on screenings 
(339/2011)
Issued in Helsinki on 6 April 2011
Government Decree on Screenings 
In accordance with the Government decision made on the submission of the 
Ministry of Social Affairs and Health, the following is enacted by virtue of 
section 23 of the Health Care Act (1326/2010):
Section 1
Definition of screening
For the purposes of this Decree, “screening” means examination of the 
population or a certain part of the population, or sampling in order to discover 
a certain disease or its precursor or to identify a pathogen.
Screening is part of preventive health care. Screening includes the definition 
of the target group, individual advice and guidance, performing and analysing 
the screening tests, delivery of feedback information, referral to further 
examinations and organization of the necessary health services.
Section 2
National screening programmes
The following are screening programmes compliant with the national 
screening programme:
1) Breast cancer screening every 20–26 months for women aged between 50 
and 69 who were born in 1947 or later;
2) Cervix cancer screening every five years for women aged between 30 and 
60; 
3) For pregnant women:
a) a general early pregnancy ultrasound scan during week 10+0–13+6 of the 
pregnancy;
b) detection of chromosomal abnormalities primarily through early pregnancy 
combined screening (serum screen test in week 9+0–11+6 of the pregnancy and 
the measurement of neck oedema in connection with a general ultrasound 
scan in week 11+0–13+6 of the pregnancy) or, alternatively, through a second 
trimester serum screen test in week 15+0–16+6 of the pregnancy; and
c) an ultrasound scan for the detection of severe structural abnormalities in 
week 18+0–21+6 of the pregnancy or after week 24+0 of the pregnancy.
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Section 3
Other screening programmes
If the municipality provides screening programmes other than those included 
in the national screening programme, it shall assess, before starting any 
screening, the requirements and impacts imposed on the health care system 
and how screening affects it. The assessment shall include an examination of 
the disease to be screened, its incidence and treatment, screening methods, 
effectiveness, organization and total costs of screening, as well as the ethical 
aspects relating to screening.
Section 4
Organization of screening programmes
The screening shall be organized in accordance with a programme established 
by the municipality in advance, taking sufficient quality control and quality 
assurance procedures  into account.
In order to provide appropriate screening services, the municipality shall 
monitor and evaluate the quality of the entire screening process and the 
reliability of the screen tests on a regular basis.
Section 5
Participation in the screening
All of the municipality’s inhabitants that belong to the screening group shall 
be entitled to participate in the screening on equal grounds. The participation 
in the screening is voluntary.
The municipality shall ensure that its inhabitants have access to sufficient 
information on the objectives and effectiveness of the screening, the possible 
risks involved with the screening, and the organization of the screening.
The health services shall be organized in such a way that there is no 
discrimination between the municipality’s inhabitants who have participated 
or intend to participate and those who have not participated or do not 
intend to participate in the screening organized under the national screening 
programme or some other screening organized by the municipality.
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Section 6
Special conditions
The health care unit participating in the collection, analysis, feedback delivery 
and further examination of the screening samples shall have sufficient 
expertise, as well as the necessary staff and equipment, at its disposal.
The municipality shall appoint a supervisor for each screening.
Section 7
Direction and monitoring
The National Institute for Health and Welfare shall monitor and evaluate the 
ongoing screening programmes and their methods in collaboration with other 
operators in the sector.
Section 8
Entry into force
This Decree enters into force on 1 May 2011.
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aPPendix 1.   exaMPles of VarioUs tyPes of HealtH 
exaMinations, tHeir target groUPs, 
Mandatory natUre, coVerage, 
screening eleMents and oBJectiVes.
Health ex-
amination
Target 
and age 
group
Mandatory 
health ex-
amination
 (yes/no, 
reference)
Cover-
age (% of 
the target 
group par-
ticipating, 
estimate?)
Screening ele-
ments included 
in the health 
examination
Objective
Maternity clinic 
examinations
Families 
expecting a 
child
yes (Health 
Care Act 
1326/2010, 
Gov. Decree 
338/2011)
Periodic health 
examinations 
(primarily 9+2, 
THL Guide-
book) incl. 
1 extensive 
health examina-
tion
99.8% (birth 
registry, THL)
Foetal health
Health of the ex-
pecting mother
Health of the whole 
family
(Äitiys-neuvola-
opas THL, 29/2013, 
luku 7.6)
Extensive health 
examination *) : 
1) strengthens the 
capabilities, health 
and well-being of 
the child, parents 
and entire family, 
2) allows for the 
earlier identification 
of the needs for 
family and family 
member support 
3) ensures the 
right-timing and 
provision of sup-
port and 
4) enhances the 
prevention of 
marginalisation 
and reduces health 
disparities.
Child health 
clinic examina-
tions
Children 
under school 
age (0-6 
years) and 
their families
yes (Health 
Care Act 
1326/2010, 
Gov. Decree 
338/2011)
Periodic health 
examinations 
(9+6) incl. 3 ex-
tensive health 
examinations
99.5% (vaccina-
tion coverage 
data)
Psychosocial devel-
opment
Communication, 
speech and language 
Physical health, 
growth and devel-
opment (physical 
functional capacity 
assessment)
vision and hearing
Neurological devel-
opment
Oral health
Health of the whole 
family
cf. *)
Identifies prob-
lems in the child’s 
growth, develop-
ment, health and 
well-being (incl. 
diseases, disorders) 
as well as the needs 
for support as early 
as possible
Support for the 
child and family as 
well as referral to 
examinations or 
treatment, if neces-
sary
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Health ex-
amination
Target 
and age 
group
Mandatory 
health ex-
amination
 (yes/no, 
reference)
Cover-
age (% of 
the target 
group par-
ticipating, 
estimate?)
Screening ele-
ments included 
in the health 
examination
Objective
School health 
care examina-
tions
Pupils of 
schools pro-
viding basic 
education 
(grades 1–9, 
7–15 years 
of age)
yes (Health 
Care Act 
1326/2010, 
Gov. Decree 
338/2011)
Periodic health 
examinations 
(9) incl. 3 ex-
tensive health 
examinations
approx. 100% Psychosocial de-
velopment (mental 
health)
Physical health, 
growth and devel-
opment
vision and hearing
Neurological devel-
opment
Oral health
Health of the whole 
family
Special examina-
tions needed to 
assess the health 
condition
cf. *)
Identifies prob-
lems in the child’s 
growth, develop-
ment, health and 
well-being (incl. 
diseases, disorders) 
as well as the needs 
for support as early 
as possible
Support for the 
child and family as 
well as referral to 
examinations or 
treatment, if neces-
sary
Student health 
care 
examinations
Students in 
upper sec-
ondary and 
vocational 
schools 
as well as 
students in 
institutions 
of higher 
education 
(16 years 
of age and 
over)
yes (Health 
Care Act 
1326/2010, 
Gov. Decree 
338/2011)
Periodic health 
examinations
? (Nk-julkaisu) Psychosocial de-
velopment, Physical 
health, growth and 
development
vision and hearing
Oral health
Develop an overall 
idea of the student’s 
health and well-
being (also in terms 
of coping with stud-
ies, with regard to 
mental health) and 
guide the student in 
making choices that 
promote his or her 
health
Driving licence 
examinations
when ap-
plying for 
a driving 
licence.
Moped, 
motorcycles 
and pas-
senger cars: 
70–75 years 
of age (every 
5 years).
Lorry, bus: 
68–70 years 
of age (every 
2 years).
yes
Act on Driv-
ing Licences 
386/2011
Assessment of the 
fitness to drive
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Health ex-
amination
Target 
and age 
group
Mandatory 
health ex-
amination
 (yes/no, 
reference)
Cover-
age (% of 
the target 
group par-
ticipating, 
estimate?)
Screening ele-
ments included 
in the health 
examination
Objective
Military exami-
nations
Call-up exami-
nation
Arrival exami-
nation
Discharge 
examination
Assessment of fit-
ness to serve
Occupational 
health care 
examinations
for cases involv-
ing serious risk 
of illness due to 
work
preliminary 
examination
periodic health 
examinations
examinations 
for promoting 
health and work 
ability
pre-employ-
ment examina-
tion
targeted exami-
nations
examination 
at the end of 
employment
Employees 
starting 
work involv-
ing exposure 
to physical 
hazards and 
working 
age persons 
employed in 
such work
Employed, 
working age
yes
Gov. Decree 
1485/2001
Gov. Decree 
708/2013
>90%?
?
According to expo-
sure, for example, 
hearing, spirometry, 
lung x-ray, blood or 
urine biomonitoring 
tests
For example, work 
ability index, Audit, 
bbI-15, lab tests, 
e.g. lipids, blood glu-
cose, liver function 
tests, Pvk
Prevention of work-
related illness and 
its early diagnosis
Maintaining and 
promoting health 
and work ability; 
referral to examina-
tions, treatment 
and rehabilitation; 
adapting work to 
work ability
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aPPendix 2.   exaMPles of tHe Benefits offered 
By worK MetHods and oPerating 
Models Used in Maternity and cHild 
HealtH clinic and stUdent HealtH 
care exaMinations (adaPted froM 
HaKUlinen-Viitanen  
& PelKonen 2014). 
Operating model or work 
method
Work method/operating model benefit
Growth and development 
monitoring, Updated growth 
curves and standards
Growth monitoring aids in the early diagnosis of diseases and disorders 
that affect growth as well as targeting treatment to those who need 
it. These diseases and disorders include malabsorptive disorders (e.g. 
coeliac disease), chronic diseases, endocrine diseases (e.g. hyperthyreosis 
and precocious puberty caused by excessive androgen secretion), 
chromosomal anomalies and deprivation. Monitoring height growth 
can help in making an early diagnosis and finding those who need help/
treatment. Monitoring weight accelerates the diagnosis of diseases and 
nutritional problems and promotes the prevention of weight gain.
vision examination vision and eye examinations aid in the early identification of diseases 
related to visual capacity and the eyes (e.g. congenital cataracts, 
retinoblastoma). vision is a child’s most important channel for 
interaction during their first year of life, which is why any abnormalities 
in vision and the eyes should be noticed as soon as possible. The earlier 
an abnormality in vision and the eyes presents, the more likely it will 
have an impact on the child’s development. Eye contact is part of early 
communication and any problems with it may indicate problems in visual 
capacity or the child’s overall development. The benefit of examining 
visual acuity and correction of visual capacity is evident in the child’s 
communication ability, functional skills and learning. 
Hearing examination Hearing examinations aid in the identification of hearing impairments 
and targeting of treatment. Even a minor hearing impairment can have 
an adverse effect on the child’s speech and language development as well 
as success in school and the workplace later in life. The early diagnosis 
of hearing impairment is vital to ensuring the child’s development in 
communication, speech, emotions, intelligence and motor skills.  
Speech development 
examination
Examining speech development helps to find children who are delayed 
in their language development and require additional examination and/
or speech therapy. It is in the best interests of the child and family for 
speech development problems to be identified and rehabilitation begun 
as early as possible. Properly targeted and timed support will save on 
costs, because successfully rehabilitated children suffering from language 
development problems can attend school in normal classes. 
Assessment of neurological 
development at preschool age 
and promoting development - 
Lene method
The Lene method helps in identifying early developmental abnormalities 
in children 4 years of age and initiating the necessary corrective action. 
Early intervention prevents the problem from deepening and building 
up in the area of the child’s socioemotional development. Lene is also 
effective in assessing clear learning difficulties occurring in the first years 
of school (valtonen 2006, valtonen et al. 2007).
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Operating model or work 
method
Work method/operating model benefit
Identifying nutritional habits and 
nutrition advice 
Nutrition advice has been proven to be cost-effective (kiiskinen 
et al. 2008). Among other things, it improves the quality of the diet 
by encouraging the consumption of fruits and vegetables and giving 
attention to the types of fat taken. Nutrition advice affects the 
nutritional habits of pregnant women, both in weight gain experienced 
during pregnancy and returning to a pre-pregnancy weight (Luoto et al. 
2007, kinnunen et al. 2008). As many as half of all gestational diabetes 
cases can be prevented by healthy nutritional and exercise habits 
(kinnunen & Luoto 2004, Luoto et al. 2007). Nutrition during pregnancy 
has an impact on, for example, juvenile and adult morbidity of the child 
being born (Erkkola & virtanen 2013). Nutrition advice aimed at the 
whole family is effective because learned nutritional habits can result in 
obesity both during childhood (Chen & Escarce 2010) and adulthood 
(Lagström et al. 2008, Singh et al. 2008). 
weight management Nutrition advice on its own or together with exercise intervention has 
been proven to be cost-effective (kiiskinen et al. 2008). The prevention 
of Type 2 diabetes has been shown to be cost-effective. Obesity, which is 
a major public health problem, causes a wide variety of diseases, which 
can be treated and prevented by losing weight.
Exercise habit assessment and 
advice 
The impact that exercise has on maintaining health and well-being and 
preventing disease is undeniable (Sääkslahti 2005, kiiskinen et al. 2008). 
Exercise protects against cardiovascular diseases, Type 2 diabetes and 
cerebral circulation disorders as well as lowers blood pressure. Health 
advice can be used to increase the amount of exercise a family gets. 
Advice on the identification, 
prevention and reduction of 
smoking as well as quitting
The impacts of smoking on health are undeniable. Among other things, 
mothers who smoke during pregnancy have a 50% higher risk of giving 
birth to an underweight child than a non-smoking mother (Räisänen 
et al. 2013). Interventions to cut down on/quit smoking made by 
primary health care professionals have been proven to be cost-effective 
(kiiskinen et al. 2008). A programme for quitting smoking aimed at 
pregnant women reduces their smoking, the number of premature births 
and number of underweight children born (Melvin et al. 2000). when the 
parents of small children quit smoking, it reduces the children’s exposure 
to cigarette smoke. It is possible to reduce the incidence of juvenile 
smoking by getting their parents to quit (kallio et al. 2006). 
Identifying the consumption of 
alcohol and advice on reducing 
its consumption - Audit form 
The mini-intervention implemented in primary health care is cost-
effective and may save on costs (kiiskinen et al. 2008). Of the various 
intoxicants available, alcohol causes the greatest amount of foetal defects 
(O’Leary 2004, Autti-Rämö 2011). The physical and emotional treatment 
of children (early interaction, attachment) has been increasingly 
neglected in families where the parents consume intoxicants (Pohjola et 
al. 2007, Pajulo & kalland 2006). Maternal substance abuse is the most 
common reason for taking small children into protective care (Sarkola 
et al. 2007). The parents’ model for alcoholic consumption influences the 
child’s later alcohol consumption habits (Seljamo et al. 2006). 
Assessment of substance abuse 
among young people and a 
health discussion for promoting 
sobriety; Adolescents’ Substance 
Use Measurement (ADSUME)
ADSUME is suitable for use in health examinations for secondary school 
students (grades 8 and 9) (Pirskanen 2007). It helps in recognising the 
adverse effects of substance abuse (accidents, injury to others, conflicts, 
careless sexual relations), which are difficult for young people to 
associate with large doses of alcohol.  
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Operating model or work 
method
Work method/operating model benefit
Identification of postnatal 
depression and its prevention 
and treatment; Edinburgh 
Postnatal Depression Scale 
(EPDS) 
Discussing depression and the related EPDS form are effective methods 
for identifying depression symptoms and targeting support for those 
who need it (Gibson et al. 2009, Hewitt et al. 2009). The EPDS form is, 
however, not suitable for making a diagnosis. A majority of depression 
cases are minor and can be treated by means of information and 
psychosocial support available at maternity clinics (Glavin 2012). The 
early prevention and identification of postnatal depression is crucial 
because its symptoms become a part of the whole family’s routine (Misri 
& kendrick 2008).
Identification of affective 
symptoms among young people 
and early support, Raitasalo beck 
Depression Inventory (RbDI13)
The RbDI13 is suitable for identifying affective symptoms among young 
people and can also be used to screen for psychological symptoms 
requiring treatment. Although adolescence often involves a variety 
of emotional symptoms, these may also be accompanied by clearly 
distinguishable symptoms, which affect the daily routine of the young 
persons concerned and can cause them great suffering. Psychological 
symptoms can be examined and the situation can be improved with 
suitable treatment. Proactive treatment administered as early as possible 
is vital to improving the diagnosis. (karlsson & Marttunen 2007, Raitasalo 
2007)  
Identification of and early 
intervention in interpersonal 
and domestic violence as well as 
child abuse
The entire family benefits from identification of and early intervention 
in interpersonal and domestic violence as well as child abuse. violence 
may lead to death or permanent disability. violence is linked to parental 
mental health problems, substance abuse and relationship problems. 
being exposed to interpersonal and domestic violence and child abuse is 
a threat to the growth and balanced development of the child. 
Identification of and supporting 
early interaction
Supporting early interaction at the maternity clinic can prevent and cure 
mental health problems in the child. by providing support, it is possible 
to improve interaction between the child and parents, thus reducing 
attachment problems. (Puura et al. 2011, Puura et al. 2002.) The early 
detection of interaction problems allows for the early identification of 
children whose psychological development is threatened, thus helping 
them at an early stage (Mäntymaa et al. 2003, Mäntymaa 2006). Providing 
interaction support for mothers with substance abuse problems, such as 
helping her to keep the baby in mind, is an effective form of treatment 
(Pajulo et al. 2006). 
Identification and strengthening 
of capabilities, Resource 
barometer questionnaires and 
motivational interviews
Identifying and providing support for a family’s capabilities enhances 
its ability to cope and reduce the level of stress (Steward-brown & 
McMillan 2011). Information facilitates a proactive effort to improve 
family life. A motivational interview is an effective tool for improving 
health habits, such as by reducing stress, depression and substance abuse 
(Lundahl et al. 2010). 
Let’s Talk About the Children 
method
The Let’s Talk About the Children method is based on opportunities for 
parents to support their children’s development and protective factors. 
This treatment for interaction between the parents and child has proven 
to be an effective method for preventing and correcting mental health 
problems in children. The method reduces the child’s psychosocial 
symptoms and promotes the support of prosocial behaviour, cognitive 
role-taking ability and empathy. (Solantaus et al. 2010. )
Identification of the need for 
peer support and its channelling 
to families, parental group 
activities
Group activities offered to all parents in a given age group has been 
proven to bring savings (Nilsson & wadeskog 2008). Family coaching in 
small groups has been proven to expand social networks and improve 
the receiving of support.
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Operating model or work 
method
Work method/operating model benefit
Making housecalls:  Advice and 
guidance 
Advice and guidance included in housecalls has been shown to have 
an impact on parental skills, interaction between the parents and child, 
the duration of nursing, identification of postnatal depression and 
the prevention of accidents and child abuse (Elkan et al. 2000, bull et 
al. 2004, wilson et al. 2007). The impact of housecalls is particularly 
evident in families needing special support. Maternity and child health 
clinic housecalls can have an impact on the life skills of mothers with 
income difficulties and relationship continuity as well as the reduction 
of substance abuse and child abuse (Olds et al. 2010, barlow et al. 2007, 
Donelan-McCall et al. 2009).
